<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
<url><loc>https://curecurrent.com/trials/treatment-of-chronic-cryptosporidiosis-in-aids-patients-131515</loc></url>
<url><loc>https://curecurrent.com/trials/vitamin-a-to-reduce-hiv-in-vaginal-secretions-and-prevent-viral-transmission-131516</loc></url>
<url><loc>https://curecurrent.com/trials/a-pilot-study-of-immunization-with-hiv-1-antigen-pulsed-allogenic-dendritic-cells-in-hiv-infected-asymptomatic-patients-131517</loc></url>
<url><loc>https://curecurrent.com/trials/safety-and-efficacy-of-cobicistat-boosted-darunavir-in-hiv-infected-adults-131518</loc></url>
<url><loc>https://curecurrent.com/trials/interleukin-12-il-12-for-the-treatment-of-cryptosporidiosis-in-aids-patients-131519</loc></url>
<url><loc>https://curecurrent.com/trials/pilot-study-evaluating-the-use-of-simultaneous-hbv-hcv-and-hiv-rapid-tests-131520</loc></url>
<url><loc>https://curecurrent.com/trials/pioglitazone-to-treat-fatty-liver-in-patients-with-hiv-and-hepatitis-c-infections-131521</loc></url>
<url><loc>https://curecurrent.com/trials/pk-of-efavirenz-lopinavir-nano-formulations-in-healthy-volunteers-131522</loc></url>
<url><loc>https://curecurrent.com/trials/a-post-marketing-survey-study-to-evaluate-the-safety-and-effectiveness-of-prezista-131523</loc></url>
<url><loc>https://curecurrent.com/trials/tipranavir-in-patients-with-progressive-systemic-hiv-1-disease-who-have-failed-or-are-intolerant-to-currently-approved-t-131524</loc></url>
<url><loc>https://curecurrent.com/trials/tipranavir-expanded-access-program-eap-in-pi-experienced-patients-with-hiv-1-infection-131525</loc></url>
<url><loc>https://curecurrent.com/trials/folinic-acid-supplementation-and-therapy-131526</loc></url>
<url><loc>https://curecurrent.com/trials/the-prenaps-study-fi-nutrition-and-psychosocial-health-outcomes-at-gulu-regional-referral-hospital-131527</loc></url>
<url><loc>https://curecurrent.com/trials/an-open-label-safety-study-of-tipranavir-co-administered-with-low-dose-ritonavir-in-patients-with-advanced-hiv-1-infecti-131528</loc></url>
<url><loc>https://curecurrent.com/trials/interferon-alfa-sensitivity-in-hiv-hcv-persons-before-and-after-hiv-meds-131529</loc></url>
<url><loc>https://curecurrent.com/trials/trial-of-collaborative-depression-care-management-for-hiv-patients-131530</loc></url>
<url><loc>https://curecurrent.com/trials/immediate-versus-deferred-antiretroviral-therapy-in-hiv-infected-patients-presenting-with-acute-aids-defining-events-131531</loc></url>
<url><loc>https://curecurrent.com/trials/mothers-living-with-hiv-and-their-adolescent-children-131532</loc></url>
<url><loc>https://curecurrent.com/trials/an-hiv-intervention-for-black-men-at-risk-the-enhanced-sexual-health-intervention-for-men-es-him-131533</loc></url>
<url><loc>https://curecurrent.com/trials/a-parenting-and-self-care-intervention-for-hiv-infected-mothers-131534</loc></url>
<url><loc>https://curecurrent.com/trials/cognitive-remediation-for-hiv-associated-neurocognitive-dysfunction-131535</loc></url>
<url><loc>https://curecurrent.com/trials/fluoride-metabolism-bone-remodelling-and-mineral-density-in-hiv-patients-treated-with-tenofovir-emtricitabine-131536</loc></url>
<url><loc>https://curecurrent.com/trials/acceptability-feasibility-of-hiv-testing-by-elisa-or-rapid-test-to-adult-patients-in-paris-france-131537</loc></url>
<url><loc>https://curecurrent.com/trials/trial-of-the-safety-and-immunogenicity-of-an-oral-replicating-ad26-vectored-hiv-1-vaccine-131538</loc></url>
<url><loc>https://curecurrent.com/trials/aims-study-improving-hiv-treatment-adherence-131539</loc></url>
<url><loc>https://curecurrent.com/trials/treatment-with-probiotics-saccharomyces-boulardii-and-its-role-in-bacterial-translocation-and-immune-reconstitution-in-v-131540</loc></url>
<url><loc>https://curecurrent.com/trials/cognition-metabolism-and-exercise-among-women-living-with-hiv-in-puerto-rico-131541</loc></url>
<url><loc>https://curecurrent.com/trials/the-safety-and-immunogenicity-of-the-dna-gtu-vaccine-administered-to-hiv-infected-patients-on-art-vs-placebo-131542</loc></url>
<url><loc>https://curecurrent.com/trials/prospective-study-of-lymphoproliferative-diseases-131543</loc></url>
<url><loc>https://curecurrent.com/trials/a-study-of-hiv-in-newly-infected-individuals-131544</loc></url>
<url><loc>https://curecurrent.com/trials/a-study-of-zidovudine-in-the-prevention-of-hiv-infection-in-individuals-exposed-to-the-virus-131545</loc></url>
<url><loc>https://curecurrent.com/trials/phase-i-trial-of-an-intervention-to-increase-condom-use-by-hiv-discordant-couples-131546</loc></url>
<url><loc>https://curecurrent.com/trials/an-observational-study-of-induction-therapy-with-fuzeon-enfuvirtide-in-combination-with-antiretroviral-drugs-in-patients-131547</loc></url>
<url><loc>https://curecurrent.com/trials/optimizing-integrated-pmtct-services-in-rural-north-central-nigeria-131548</loc></url>
<url><loc>https://curecurrent.com/trials/a-study-of-enfuvirtide-fuzeon-in-patients-with-advanced-human-immunodeficiency-virus-1-hiv-1-infection-131549</loc></url>
<url><loc>https://curecurrent.com/trials/a-study-of-ritonavir-boosted-invirase-saquinavir-in-treatment-na-ve-hiv-1-infected-patients-131550</loc></url>
<url><loc>https://curecurrent.com/trials/observational-study-on-predictors-of-response-to-invirase-saquinavir-treatment-in-treatment-na-ve-patients-with-hiv-infe-131551</loc></url>
<url><loc>https://curecurrent.com/trials/a-study-comparing-the-efficacy-and-safety-of-once-daily-fuzeon-enfuvirtide-dosing-versus-the-currently-recommended-twice-131552</loc></url>
<url><loc>https://curecurrent.com/trials/contingency-management-in-the-delivery-of-haart-to-drug-users-in-chennai-india-131553</loc></url>
<url><loc>https://curecurrent.com/trials/qualite-study-a-study-of-fuzeon-enfuvirtide-in-treatment-experienced-patients-with-human-immunodeficiency-virus-1-hiv-1-131554</loc></url>
<url><loc>https://curecurrent.com/trials/collection-of-blood-samples-from-smart-study-participants-for-future-genetic-studies-131555</loc></url>
<url><loc>https://curecurrent.com/trials/compassionate-use-of-ibalizumab-for-the-treatment-of-hiv-infection-131556</loc></url>
<url><loc>https://curecurrent.com/trials/hiv-eradication-through-cord-blood-transplantation-131557</loc></url>
<url><loc>https://curecurrent.com/trials/the-effect-of-acyclovir-treatment-of-the-herpes-simplex-virus-hsv-infection-on-hiv-levels-in-the-blood-131558</loc></url>
<url><loc>https://curecurrent.com/trials/a-test-of-behavioral-intervention-for-women-at-high-risk-for-hiv-infection-131559</loc></url>
<url><loc>https://curecurrent.com/trials/a-treatment-ind-for-retrovir-brand-zidovudine-azt-therapy-of-pediatric-patients-with-hiv-disease-131560</loc></url>
<url><loc>https://curecurrent.com/trials/pepi-tidp23-c104-is-a-first-in-human-study-with-a-single-dose-escalation-part-and-a-multiple-dosing-part-for-compounds-t-131561</loc></url>
<url><loc>https://curecurrent.com/trials/adherence-health-outcome-differences-amongst-hiv-infected-patients-prescribed-haart-131562</loc></url>
<url><loc>https://curecurrent.com/trials/effect-of-schistosomiasis-mansoni-on-hiv-susceptibility-and-female-genital-immunology-131563</loc></url>
<url><loc>https://curecurrent.com/trials/a-randomized-controlled-trial-of-the-bruthas-project-131564</loc></url>
<url><loc>https://curecurrent.com/trials/hcv-treatment-in-hiv-co-infected-patients-in-asia-131565</loc></url>
<url><loc>https://curecurrent.com/trials/rapid-diagnostic-tests-and-clinical-laboratory-predictors-of-tropical-diseases-in-patients-with-persistent-fever-in-camb-131566</loc></url>
<url><loc>https://curecurrent.com/trials/influence-of-pravastatin-on-carotid-artery-structure-and-function-in-hiv-infected-patients-under-antiretroviral-therapy-131567</loc></url>
<url><loc>https://curecurrent.com/trials/the-spot-project-motivational-interviewing-in-conjunction-with-rapid-hiv-testing-131568</loc></url>
<url><loc>https://curecurrent.com/trials/prevalence-of-cerebral-small-vessel-disease-in-hiv-infected-patients-131569</loc></url>
<url><loc>https://curecurrent.com/trials/dvd-based-hiv-hcv-prevention-intervention-for-drug-involved-latino-criminal-justice-clients-131570</loc></url>
<url><loc>https://curecurrent.com/trials/revealing-increased-axonal-loss-in-treated-hiv-patients-131571</loc></url>
<url><loc>https://curecurrent.com/trials/neurocognitive-effects-and-tolerability-of-efavirenz-in-aging-hiv-infected-individuals-shac-neuro-study-131572</loc></url>
<url><loc>https://curecurrent.com/trials/real-life-security-and-efficacy-of-daa-based-therapy-in-hcv-hiv-coinfected-patients-131573</loc></url>
<url><loc>https://curecurrent.com/trials/ilink-incentives-for-linkage-to-art-study-a-mixed-methods-study-to-improve-linkage-to-hiv-care-131574</loc></url>
<url><loc>https://curecurrent.com/trials/pilot-study-to-describe-immune-responses-of-healthy-women-following-immunization-with-varicella-zoster-virus-vaccine-131575</loc></url>
<url><loc>https://curecurrent.com/trials/pre-exposure-prophylaxis-acceptability-readiness-assessments-for-toronto-gay-bisexual-and-other-men-who-have-sex-with-me-131576</loc></url>
<url><loc>https://curecurrent.com/trials/adding-maraviroc-to-the-haart-regimen-of-well-controlled-hiv-infected-patients-131577</loc></url>
<url><loc>https://curecurrent.com/trials/inhalation-nasal-corticosteroids-and-prevalence-of-hypothalamic-pituitary-adrenal-hpa-axis-suppression-in-human-immunode-131578</loc></url>
<url><loc>https://curecurrent.com/trials/brazilian-hiv-sexually-transmitted-infection-sti-prevention-for-adolescents-with-mental-health-disorder-131579</loc></url>
<url><loc>https://curecurrent.com/trials/prep-with-tdf-ftc-to-prevent-hiv-1-acquisition-in-young-msm-and-transgender-women-of-color-131580</loc></url>
<url><loc>https://curecurrent.com/trials/the-effect-of-probiotics-on-microbial-translocation-and-inflammation-in-hiv-infected-patients-131581</loc></url>
<url><loc>https://curecurrent.com/trials/same-day-hiv-testing-and-treatment-initiation-to-improve-retention-in-care-131582</loc></url>
<url><loc>https://curecurrent.com/trials/a-controlled-study-of-the-safety-and-efficacy-of-lessertia-frutescens-in-hiv-infected-south-african-adults-131583</loc></url>
<url><loc>https://curecurrent.com/trials/effects-of-pitavastatin-on-lipid-profiles-in-hiv-infected-patients-with-dyslipidemia-and-receiving-atazanavir-ritonavir-131584</loc></url>
<url><loc>https://curecurrent.com/trials/intervention-targeting-substance-using-older-adults-with-hiv-131585</loc></url>
<url><loc>https://curecurrent.com/trials/seek-test-treat-strategies-for-vietnamese-drug-users-a-randomized-controlled-trial-131586</loc></url>
<url><loc>https://curecurrent.com/trials/heterosexual-hiv-transmission-study-hats-131587</loc></url>
<url><loc>https://curecurrent.com/trials/pilot-simplification-study-to-lopinavir-ritonavir-800-200-mg-monotherapy-regimen-once-daily-131588</loc></url>
<url><loc>https://curecurrent.com/trials/dolutegravir-interactions-with-artemisinin-based-combination-therapies-131589</loc></url>
<url><loc>https://curecurrent.com/trials/integrated-mental-health-treatment-hiv-prevention-for-court-involved-youth-131590</loc></url>
<url><loc>https://curecurrent.com/trials/rewarding-adherence-program-an-intervention-using-small-prizes-allocated-by-a-prize-drawing-to-increase-arv-adherence-131591</loc></url>
<url><loc>https://curecurrent.com/trials/implementation-of-a-sexual-health-intervention-for-young-men-who-have-sex-with-men-msm-in-two-vietnamese-cities-131592</loc></url>
<url><loc>https://curecurrent.com/trials/asha-hiv-health-promotion-intervention-in-india-131593</loc></url>
<url><loc>https://curecurrent.com/trials/investigating-immunisation-strategies-of-dna-mva-and-cn54rgp140-adjuvanted-with-gla-af-to-maximise-antibody-responses-131594</loc></url>
<url><loc>https://curecurrent.com/trials/tenofovir-pharmacology-in-older-hiv-infected-individuals-131595</loc></url>
<url><loc>https://curecurrent.com/trials/drug-interaction-study-of-lopinavir-ritonavir-and-gemfibrozil-131596</loc></url>
<url><loc>https://curecurrent.com/trials/immunogenicity-of-fluzone-hd-a-high-dose-influenza-vaccine-in-children-with-cancer-or-hiv-131597</loc></url>
<url><loc>https://curecurrent.com/trials/raltegravir-switch-study-to-reduce-liver-fibrosis-progression-in-hiv-hepatitis-c-co-infection-131598</loc></url>
<url><loc>https://curecurrent.com/trials/randomized-control-trial-of-family-based-hiv-prevention-for-latinos-131599</loc></url>
<url><loc>https://curecurrent.com/trials/contingency-management-for-methamphetamine-abstinence-and-hiv-post-exposure-prophylaxis-in-men-who-have-sex-with-men-131600</loc></url>
<url><loc>https://curecurrent.com/trials/tmc114-c202-a-study-of-safety-efficacy-and-tolerability-of-tmc114-and-low-dose-ritonavir-in-hiv-1-infected-patients-131601</loc></url>
<url><loc>https://curecurrent.com/trials/a-phase-iv-study-of-bms-232632-in-hiv-patients-with-metabolic-syndrome-131602</loc></url>
<url><loc>https://curecurrent.com/trials/differences-in-malaria-infection-levels-in-hiv-infected-infants-and-children-receiving-pi-and-nnrti-based-haart-131603</loc></url>
<url><loc>https://curecurrent.com/trials/knowledge-attitudes-beliefs-and-practices-relative-to-hiv-among-sex-workers-in-french-guiana-131604</loc></url>
<url><loc>https://curecurrent.com/trials/knowledge-attitudes-beliefs-and-practices-regarding-hiv-in-populations-living-on-the-maroni-river-131605</loc></url>
<url><loc>https://curecurrent.com/trials/knowledge-attitudes-beliefs-and-practices-regarding-hiv-among-teenagers-in-french-guiana-131606</loc></url>
<url><loc>https://curecurrent.com/trials/lung-hiv-microbiome-project-michigan-site-131607</loc></url>
<url><loc>https://curecurrent.com/trials/sustained-virological-suppression-and-improvement-of-adverse-events-of-switching-to-raltegravir-study-131608</loc></url>
<url><loc>https://curecurrent.com/trials/study-of-a-combination-pill-with-gs-7977-and-gs-5885-for-hepatitis-c-in-people-with-hiv-131609</loc></url>
<url><loc>https://curecurrent.com/trials/predicting-treatment-and-care-difficulties-among-hiv-infected-patients-131610</loc></url>
<url><loc>https://curecurrent.com/trials/changes-in-lipids-and-lipoproteins-in-hiv-infected-women-after-switch-from-protease-inhibitor-to-raltegravir-131611</loc></url>
<url><loc>https://curecurrent.com/trials/fosamprenavir-expanded-access-131612</loc></url>
<url><loc>https://curecurrent.com/trials/peer-groups-for-healthy-pregnancy-hiv-prevention-for-young-malawian-women-131613</loc></url>
<url><loc>https://curecurrent.com/trials/boston-alcohol-research-collaboration-on-hiv-aids-arch-cohort-131614</loc></url>
<url><loc>https://curecurrent.com/trials/use-of-concomitant-medications-in-hiv-1-infected-patients-in-a-large-community-practice-in-sydney-australia-131615</loc></url>
<url><loc>https://curecurrent.com/trials/safety-and-immunogenicity-of-aeras-402-in-hiv-infected-bacillus-calmette-guerin-bcg-vaccinated-adults-131616</loc></url>
<url><loc>https://curecurrent.com/trials/retrospective-study-of-the-survival-of-patients-suffering-from-hiv-related-progressive-multifocal-leukoencephalopathy-131617</loc></url>
<url><loc>https://curecurrent.com/trials/methadone-maintenance-hiv-risk-in-ukraine-131618</loc></url>
<url><loc>https://curecurrent.com/trials/feasibility-of-an-ingestible-sensor-system-to-measure-prep-adherence-in-ymsm-131619</loc></url>
<url><loc>https://curecurrent.com/trials/pegasys-long-term-anti-fibrotic-effect-co-infection-trial-perfect-131620</loc></url>
<url><loc>https://curecurrent.com/trials/exploratory-pharmacodynamic-study-of-tenofovir-based-products-131621</loc></url>
<url><loc>https://curecurrent.com/trials/hiv-internet-sex-study-internet-based-sti-hiv-prevention-for-hiv-internet-users-131622</loc></url>
<url><loc>https://curecurrent.com/trials/development-of-adherence-biomarkers-for-multiple-microbicide-and-multipurpose-prevention-technology-mpt-dosage-forms-131623</loc></url>
<url><loc>https://curecurrent.com/trials/longitudinal-studies-of-hiv-associated-lung-infections-and-complications-lung-hiv-131624</loc></url>
<url><loc>https://curecurrent.com/trials/redistribution-of-fat-and-metabolic-change-in-hiv-infection-protocol-2-fram-fat-2-131625</loc></url>
<url><loc>https://curecurrent.com/trials/a-computer-based-parent-adolescent-hiv-communication-intervention-for-latinos-131626</loc></url>
<url><loc>https://curecurrent.com/trials/treatment-with-indinavir-and-chemotherapy-for-advanced-classical-kaposi-s-sarcoma-131627</loc></url>
<url><loc>https://curecurrent.com/trials/phase-iii-trial-of-bi-201335-faldaprevir-in-treatment-naive-tn-and-relapser-hepatitis-c-virus-hcv-human-immunodeficiency-131628</loc></url>
<url><loc>https://curecurrent.com/trials/development-of-a-novel-hiv-risk-reduction-intervention-for-abused-women-131629</loc></url>
<url><loc>https://curecurrent.com/trials/expanded-use-pk-of-dapivirine-vaginal-ring-131630</loc></url>
<url><loc>https://curecurrent.com/trials/pennvax-b-with-or-without-il-12-or-il-15-as-a-dna-vaccine-for-hiv-infection-131631</loc></url>
<url><loc>https://curecurrent.com/trials/esp-study-a-study-to-assess-the-effect-of-adding-fuzeon-enfuvirtide-to-an-antiretroviral-regimen-in-fuzeon-naive-patient-131632</loc></url>
<url><loc>https://curecurrent.com/trials/maternal-hiv-disclosure-to-school-children-rct-of-family-based-intervention-131633</loc></url>
<url><loc>https://curecurrent.com/trials/anal-dysplasia-study-of-men-who-have-sex-with-men-living-with-hiv-131634</loc></url>
<url><loc>https://curecurrent.com/trials/high-dose-therapy-and-peripheral-blood-stem-cell-transplantation-in-hiv-related-non-hodgkin-lymphoma-nhl-at-high-risk-131635</loc></url>
<url><loc>https://curecurrent.com/trials/hiv-risk-reduction-in-subutex-injectors-in-tbilisi-131636</loc></url>
<url><loc>https://curecurrent.com/trials/safety-study-of-multikine-in-the-treatment-of-perianal-warts-131637</loc></url>
<url><loc>https://curecurrent.com/trials/testing-and-linkage-to-hiv-care-in-china-131638</loc></url>
<url><loc>https://curecurrent.com/trials/telaprevir-open-label-study-in-co-infected-patients-131639</loc></url>
<url><loc>https://curecurrent.com/trials/low-dose-atazanavir-r-versus-standard-dose-atazanavir-r-lasa-131640</loc></url>
<url><loc>https://curecurrent.com/trials/relationship-of-metabolic-abnormalities-to-hepatic-steatosis-in-hiv-131641</loc></url>
<url><loc>https://curecurrent.com/trials/meaning-of-life-in-hiv-infected-youths-131642</loc></url>
<url><loc>https://curecurrent.com/trials/factors-affecting-patient-participation-in-aids-malignancy-clinical-trials-consortium-clinical-trials-131643</loc></url>
<url><loc>https://curecurrent.com/trials/impact-of-extremely-early-antiretroviral-therapy-to-reduce-viral-reservoir-and-induce-functional-cure-of-hiv-1-infection-131644</loc></url>
<url><loc>https://curecurrent.com/trials/efficacy-of-drug-and-risk-counseling-among-methadone-patients-in-jakarta-indonesia-131645</loc></url>
<url><loc>https://curecurrent.com/trials/efficacy-and-safety-of-peg-interferon-alpha-2a-plus-ribavirin-in-genotype-1-chronic-hepatitis-c-participants-co-infected-131646</loc></url>
<url><loc>https://curecurrent.com/trials/blq-study-a-study-of-a-protease-inhibitor-with-fuzeon-enfuvirtide-in-treatment-experienced-patients-with-hiv-1-131647</loc></url>
<url><loc>https://curecurrent.com/trials/ssat061-pk-of-dtg-and-evt-cobi-in-healthy-volunteers-131648</loc></url>
<url><loc>https://curecurrent.com/trials/hiv-and-drug-use-in-georgian-women-131649</loc></url>
<url><loc>https://curecurrent.com/trials/transitions-linkages-from-jail-to-community-131650</loc></url>
<url><loc>https://curecurrent.com/trials/massage-therapy-for-hiv-positive-people-effects-on-anxiety-depression-hyperventilation-and-quality-of-life-131651</loc></url>
<url><loc>https://curecurrent.com/trials/relative-bioavailability-study-of-gsk1265744-formulations-131652</loc></url>
<url><loc>https://curecurrent.com/trials/cybersenga-internet-based-hiv-prevention-in-uganda-131653</loc></url>
<url><loc>https://curecurrent.com/trials/tailored-nutrition-and-food-security-interventions-in-comprehensive-hiv-care-131654</loc></url>
<url><loc>https://curecurrent.com/trials/hiv-prevention-and-trauma-treatment-in-men-who-have-sex-with-men-and-who-have-a-history-of-sexual-abuse-131655</loc></url>
<url><loc>https://curecurrent.com/trials/birmingham-access-to-care-study-131656</loc></url>
<url><loc>https://curecurrent.com/trials/efficacy-of-neuro-haart-in-patients-with-hiv-131657</loc></url>
<url><loc>https://curecurrent.com/trials/hiv-prevention-in-very-high-risk-men-who-have-sex-with-men-131658</loc></url>
<url><loc>https://curecurrent.com/trials/physiologic-investigation-of-the-renin-angiotensin-aldosterone-axis-in-hiv-131659</loc></url>
<url><loc>https://curecurrent.com/trials/sofosbuvir-ribavirin-for-the-treatment-of-chronic-hepatitis-c-virus-genotype-1-in-hiv-coinfected-patients-receiving-fixe-131660</loc></url>
<url><loc>https://curecurrent.com/trials/simplifying-the-shang-ring-technique-for-circumcision-of-men-and-boys-131661</loc></url>
<url><loc>https://curecurrent.com/trials/comprehensive-analysis-of-hiv-reservoirs-in-chronically-infected-hiv-1-treated-patients-131662</loc></url>
<url><loc>https://curecurrent.com/trials/medication-adherence-in-human-immunodeficiency-virus-hiv-131663</loc></url>
<url><loc>https://curecurrent.com/trials/phase-i-trial-of-dar-901-131664</loc></url>
<url><loc>https://curecurrent.com/trials/neurobehavioral-model-of-hiv-in-injection-drug-users-131665</loc></url>
<url><loc>https://curecurrent.com/trials/a-phase-i-trial-to-assess-the-safety-of-tenofovir-gel-and-film-formulations-fame-04-131666</loc></url>
<url><loc>https://curecurrent.com/trials/seroprevalence-of-chikungunya-at-the-end-of-the-first-chikungunya-outbreak-in-the-french-antilles-within-a-sample-of-pat-131667</loc></url>
<url><loc>https://curecurrent.com/trials/the-effect-of-hpv-vaccination-on-recurrence-rates-in-hiv-patients-with-condylomata-131668</loc></url>
<url><loc>https://curecurrent.com/trials/antiretroviral-treatment-simplified-follow-up-management-assessment-anrs-12110-stratall-131669</loc></url>
<url><loc>https://curecurrent.com/trials/national-evaluation-of-pi-based-2nd-line-efficacy-in-cambodia-131670</loc></url>
<url><loc>https://curecurrent.com/trials/computer-mi-for-tobacco-quitline-engagement-in-smokers-living-with-hiv-131671</loc></url>
<url><loc>https://curecurrent.com/trials/thol-impilo-bringing-people-into-care-131672</loc></url>
<url><loc>https://curecurrent.com/trials/efficacy-and-safety-of-ledipasvir-sofosbuvir-fixed-dose-combination-for-8-weeks-in-subjects-with-chronic-genotype-1-hcv-131673</loc></url>
<url><loc>https://curecurrent.com/trials/study-of-anti-hiv-cellular-therapy-based-on-dendritic-cells-pulsed-with-chemically-inactivated-virus-131674</loc></url>
<url><loc>https://curecurrent.com/trials/heart-function-in-hiv-negative-children-exposed-to-hiv-and-haart-131675</loc></url>
<url><loc>https://curecurrent.com/trials/early-versus-delayed-antiretroviral-therapy-art-in-the-treatment-of-cryptococcal-meningitis-in-africa-131676</loc></url>
<url><loc>https://curecurrent.com/trials/the-effect-of-an-enhanced-rice-bran-nutritional-supplement-in-hiv-131677</loc></url>
<url><loc>https://curecurrent.com/trials/pro-140-by-iv-administration-in-adults-with-hiv-1-infection-131678</loc></url>
<url><loc>https://curecurrent.com/trials/study-of-vitamin-d-and-effect-on-heart-disease-and-insulin-resistance-131679</loc></url>
<url><loc>https://curecurrent.com/trials/a-cross-sectional-evaluation-of-the-development-in-children-age-4-to-7-infected-or-exposed-to-hiv-from-the-anrs-12140-co-131680</loc></url>
<url><loc>https://curecurrent.com/trials/h1n1-influenza-vaccine-immunogenicity-in-hiv-1-infected-patients-131681</loc></url>
<url><loc>https://curecurrent.com/trials/values-of-the-immune-activation-markers-cd38-and-hla-dr-and-the-ratio-cd4-cd8-according-to-the-delay-of-combined-antiret-131682</loc></url>
<url><loc>https://curecurrent.com/trials/physiopathology-study-of-the-microbiota-biodiversity-of-hiv-seropositive-patients-131683</loc></url>
<url><loc>https://curecurrent.com/trials/evaluation-of-simplified-antiretroviral-treatment-strategies-in-hiv-infected-children-treated-by-antiretroviral-arv-befo-131684</loc></url>
<url><loc>https://curecurrent.com/trials/viral-activation-transfusion-study-vats-131685</loc></url>
<url><loc>https://curecurrent.com/trials/disability-and-hiv-vulnerability-of-people-with-disabilities-to-hiv-infection-in-sub-saharan-africa-131686</loc></url>
<url><loc>https://curecurrent.com/trials/study-evaluating-efficiency-and-tolerance-of-high-dose-fluconazole-associated-with-flucytosine-as-induction-therapy-for-131687</loc></url>
<url><loc>https://curecurrent.com/trials/assessing-the-severity-of-metabolic-related-liver-injuries-in-aging-hiv-monoinfected-patients-131688</loc></url>
<url><loc>https://curecurrent.com/trials/immuno-stimulation-with-maraviroc-combined-to-antiretroviral-therapy-in-advanced-late-diagnosed-hiv-1-infected-patients-131689</loc></url>
<url><loc>https://curecurrent.com/trials/vitamin-d-and-calcium-supplement-attenuate-bone-loss-among-hiv-infected-patients-receiving-tenofovir-disoproxil-fumarate-131690</loc></url>
<url><loc>https://curecurrent.com/trials/epicardial-adipose-tissue-and-coronary-risk-in-hiv-infected-patients-131691</loc></url>
<url><loc>https://curecurrent.com/trials/a-study-of-enfuvirtide-fuzeon-in-participants-with-advanced-human-immunodeficiency-virus-hiv-infection-131692</loc></url>
<url><loc>https://curecurrent.com/trials/pet-ct-in-extrapulmonary-tb-in-hiv-patients-a-clinical-trial-131693</loc></url>
<url><loc>https://curecurrent.com/trials/expanded-access-program-for-maraviroc-at-multiple-centers-131694</loc></url>
<url><loc>https://curecurrent.com/trials/observational-retrospective-multicenter-study-to-describe-the-reasons-for-the-change-of-the-regimen-of-antiretroviral-th-131695</loc></url>
<url><loc>https://curecurrent.com/trials/a-prospective-with-one-site-open-label-not-controled-trial-for-the-observation-of-treatment-with-cidofovir-1-3-nights-pe-131696</loc></url>
<url><loc>https://curecurrent.com/trials/vitamin-d-and-hiv-cardiovascular-disease-in-children-and-young-adults-131697</loc></url>
<url><loc>https://curecurrent.com/trials/relative-oral-bioavailability-study-of-different-fixed-dose-combinations-of-dolutegravir-and-rilpivirine-in-healthy-subj-131698</loc></url>
<url><loc>https://curecurrent.com/trials/a-study-of-the-neurological-effects-of-adding-raltegravir-to-haart-regimen-in-patients-with-hiv-131699</loc></url>
<url><loc>https://curecurrent.com/trials/test-of-an-intervention-to-improve-hiv-care-131700</loc></url>
<url><loc>https://curecurrent.com/trials/incentives-to-promote-medication-adherence-among-hiv-infected-youth-131701</loc></url>
<url><loc>https://curecurrent.com/trials/metabolic-abnormalities-in-hiv-infected-persons-131702</loc></url>
<url><loc>https://curecurrent.com/trials/an-efficacy-and-safety-study-of-autologous-cluster-of-differentiation-34-cd34-hematopoietic-progenitor-cells-transduced-131703</loc></url>
<url><loc>https://curecurrent.com/trials/assessment-of-vac-3s-therapeutic-properties-when-combined-with-standard-art-in-the-course-of-hiv-1-infection-131704</loc></url>
<url><loc>https://curecurrent.com/trials/open-label-phase-i-iia-study-of-vac-3s-in-hiv-1-patients-who-showed-an-immune-response-to-vac-3s-during-ivvac-3s-p1-131705</loc></url>
<url><loc>https://curecurrent.com/trials/factors-associated-with-late-hiv-diagnosis-in-grampian-an-epidemiological-study-131706</loc></url>
<url><loc>https://curecurrent.com/trials/ace-inhibitors-to-decrease-lymphoid-fibrosis-in-antiretroviral-treated-hiv-infected-patients-a-pilot-study-131707</loc></url>
<url><loc>https://curecurrent.com/trials/validation-of-a-simple-and-cost-effective-nucleic-acid-test-for-hiv-detection-131708</loc></url>
<url><loc>https://curecurrent.com/trials/health-related-symptom-questionnaires-in-measuring-quality-of-life-in-hiv-infected-participants-treated-or-monitored-for-131709</loc></url>
<url><loc>https://curecurrent.com/trials/study-to-evaluate-switching-from-regimens-consisting-of-a-ritonavir-boosted-protease-inhibitor-plus-emtricitabine-tenofo-131710</loc></url>
<url><loc>https://curecurrent.com/trials/safety-and-immunogenicity-of-mva-hivconsv-in-hiv-1-seropositive-adults-on-haart-131711</loc></url>
<url><loc>https://curecurrent.com/trials/evaluation-of-the-safety-efficacy-and-pharmacokinetics-of-intravenous-deferiprone-in-hiv-positive-subjects-131712</loc></url>
<url><loc>https://curecurrent.com/trials/the-use-of-hiv-self-tests-to-promote-partner-and-couples-testing-a-randomized-trial-131713</loc></url>
<url><loc>https://curecurrent.com/trials/safety-tolerability-and-immunogenicity-study-of-2-dose-levels-of-trimeric-glycoprotein140-gp140-in-healthy-adult-volunte-131714</loc></url>
<url><loc>https://curecurrent.com/trials/evaluating-once-daily-etravirine-in-treatment-naive-adults-with-hiv-infection-131715</loc></url>
<url><loc>https://curecurrent.com/trials/the-use-of-peer-referral-incentives-to-increase-demand-for-voluntary-medical-male-circumcision-in-zambia-131716</loc></url>
<url><loc>https://curecurrent.com/trials/effects-of-treatment-with-aprepitant-emend-in-hiv-infected-individuals-375-mg-dose-131717</loc></url>
<url><loc>https://curecurrent.com/trials/bone-mineral-density-in-hiv-patients-131718</loc></url>
<url><loc>https://curecurrent.com/trials/fatigue-management-in-hiv-131719</loc></url>
<url><loc>https://curecurrent.com/trials/fracture-and-bone-mineral-density-in-hiv-patients-recently-started-on-antiretroviral-therapy-art-131720</loc></url>
<url><loc>https://curecurrent.com/trials/targeted-nurse-driven-hiv-screening-in-emergency-departments-131721</loc></url>
<url><loc>https://curecurrent.com/trials/safety-immunogenicity-of-hiv-vaccines-in-healthy-kenyan-adults-131723</loc></url>
<url><loc>https://curecurrent.com/trials/multicenter-randomized-double-blind-double-dummy-phase-3-study-of-the-safety-and-efficacy-of-elvitegravir-versus-raltegr-131724</loc></url>
<url><loc>https://curecurrent.com/trials/safety-pk-and-pd-study-of-abx464-in-untreated-hiv-patients-131725</loc></url>
<url><loc>https://curecurrent.com/trials/the-tolerability-of-and-adherence-to-dolutegravir-with-co-formulated-tenofovir-emtricitabine-for-hiv-non-occupational-po-131726</loc></url>
<url><loc>https://curecurrent.com/trials/haart-adherence-among-hiv-infected-persons-and-the-factors-affecting-treatment-adherence-131727</loc></url>
<url><loc>https://curecurrent.com/trials/a-study-of-mva85a-in-healthy-infants-131728</loc></url>
<url><loc>https://curecurrent.com/trials/primary-hiv-prevention-in-pregnant-and-lactating-ugandan-women-131729</loc></url>
<url><loc>https://curecurrent.com/trials/efficacy-against-tb-disease-safety-and-immunogenicity-of-mva85a-aeras-485-in-hiv-infected-adults-c-030-485-131730</loc></url>
<url><loc>https://curecurrent.com/trials/safety-and-efficacy-of-cobi-boosted-atazanavir-versus-ritonavir-boosted-atazanavir-each-administered-with-emtricitabine-131731</loc></url>
<url><loc>https://curecurrent.com/trials/a-study-to-assess-the-efficacy-of-raltegravir-isentress-administered-in-combination-with-other-antiretroviral-drugs-as-t-131732</loc></url>
<url><loc>https://curecurrent.com/trials/nutritional-and-metabolic-disorders-in-hiv-infected-children-and-adolescent-131733</loc></url>
<url><loc>https://curecurrent.com/trials/hiv-prevention-for-youth-with-severe-mental-illness-131734</loc></url>
<url><loc>https://curecurrent.com/trials/effectiveness-of-enhanced-counseling-and-observed-therapy-on-antiretroviral-adherence-in-people-with-hiv-131735</loc></url>
<url><loc>https://curecurrent.com/trials/formative-phase-of-reducing-hazardous-alcohol-use-hiv-viral-load-131736</loc></url>
<url><loc>https://curecurrent.com/trials/syphilis-response-to-higher-penicillin-dosage-the-2-4-versus-7-2-study-131737</loc></url>
<url><loc>https://curecurrent.com/trials/measurement-of-hiv-risk-to-create-demand-for-safe-male-circumcision-131738</loc></url>
<url><loc>https://curecurrent.com/trials/a-mindfulness-based-approach-to-hiv-treatment-side-effects-131739</loc></url>
<url><loc>https://curecurrent.com/trials/determination-of-hcv-prevalence-in-a-hiv-patient-cohort-in-phnom-penh-cambodia-131740</loc></url>
<url><loc>https://curecurrent.com/trials/benefits-and-costs-of-integrating-sexual-reproductive-health-and-hiv-services-in-kenya-and-swaziland-131741</loc></url>
<url><loc>https://curecurrent.com/trials/pre-art-retention-in-care-in-tanzania-131742</loc></url>
<url><loc>https://curecurrent.com/trials/brain-deficits-in-hiv-hcv-coinfected-people-before-and-after-anti-hcv-therapy-131743</loc></url>
<url><loc>https://curecurrent.com/trials/rct-of-russian-idu-peer-network-hiv-prevention-intervention-1-131744</loc></url>
<url><loc>https://curecurrent.com/trials/feasibility-of-an-exercise-intervention-131745</loc></url>
<url><loc>https://curecurrent.com/trials/dna-sequencing-of-mdr-tb-in-eastern-siberia-131746</loc></url>
<url><loc>https://curecurrent.com/trials/can-valacyclovir-attenuate-inflammation-in-antiretroviral-treated-hiv-infected-individuals-with-herpes-simplex-virus-typ-131747</loc></url>
<url><loc>https://curecurrent.com/trials/second-line-therapy-131748</loc></url>
<url><loc>https://curecurrent.com/trials/progress-adult-study-131749</loc></url>
<url><loc>https://curecurrent.com/trials/sexually-transmitted-infections-among-african-american-women-who-have-sex-with-women-131750</loc></url>
<url><loc>https://curecurrent.com/trials/sti-hiv-prevention-intervention-for-adolescents-in-singapore-131751</loc></url>
<url><loc>https://curecurrent.com/trials/pharmacotherapy-follow-up-in-older-hiv-infected-patients-131752</loc></url>
<url><loc>https://curecurrent.com/trials/improving-survey-procedures-for-young-men-who-have-sex-with-men-in-web-based-hiv-prevention-retention-study-131753</loc></url>
<url><loc>https://curecurrent.com/trials/vaginal-innate-immunity-in-normal-and-hiv-infected-women-131754</loc></url>
<url><loc>https://curecurrent.com/trials/rct-of-cbt-for-insomnia-with-plwha-131755</loc></url>
<url><loc>https://curecurrent.com/trials/an-efficacy-and-safety-study-of-telaprevir-in-patients-infected-with-both-chronic-hepatitis-c-virus-hcv-1-and-human-immu-131756</loc></url>
<url><loc>https://curecurrent.com/trials/targeting-hiv-risk-behaviors-in-juvenile-drug-court-involved-youth-131757</loc></url>
<url><loc>https://curecurrent.com/trials/maraviroc-compassionate-use-131758</loc></url>
<url><loc>https://curecurrent.com/trials/clinical-trial-of-recombinant-adenovirus-type-5-aids-vaccine-131759</loc></url>
<url><loc>https://curecurrent.com/trials/cobicistat-containing-highly-active-antiretroviral-regimens-in-hiv-1-infected-patients-with-mild-to-moderate-renal-impai-131760</loc></url>
<url><loc>https://curecurrent.com/trials/introducing-prep-into-hiv-combination-prevention-kenya-131761</loc></url>
<url><loc>https://curecurrent.com/trials/a-phase-i-study-to-evaluate-safety-and-immunogenicity-of-aeras-404-c-011-404-131762</loc></url>
<url><loc>https://curecurrent.com/trials/a-study-to-evaluate-safety-and-immunogenicity-of-aeras-402-administered-in-hiv-negative-bcg-vaccinated-qft-and-adults-wi-131763</loc></url>
<url><loc>https://curecurrent.com/trials/assessment-of-the-hiv-cns-reservoir-neurological-and-neuro-cognitive-effects-and-source-of-rebound-hiv-in-cns-131764</loc></url>
<url><loc>https://curecurrent.com/trials/interventions-to-improve-hiv-care-engagement-after-hospital-discharge-131765</loc></url>
<url><loc>https://curecurrent.com/trials/international-social-network-intervention-131766</loc></url>
<url><loc>https://curecurrent.com/trials/safety-of-evg-rtv-administered-with-other-antiretroviral-agents-for-the-treatment-of-hiv-1-infection-131767</loc></url>
<url><loc>https://curecurrent.com/trials/early-access-of-mk0518-in-combination-with-an-optimized-background-antiretroviral-therapy-0518-023-131768</loc></url>
<url><loc>https://curecurrent.com/trials/mhealth-intervention-supporting-hiv-treatment-adherence-and-retention-131769</loc></url>
<url><loc>https://curecurrent.com/trials/comorbidities-and-virologic-outcome-among-patients-on-anti-retroviral-therapy-in-rural-lesotho-131770</loc></url>
<url><loc>https://curecurrent.com/trials/reduction-of-early-mortality-in-hiv-infected-adults-and-children-starting-antiretroviral-therapy-131771</loc></url>
<url><loc>https://curecurrent.com/trials/substance-use-and-sexual-risk-reduction-intervention-for-homeless-youth-131772</loc></url>
<url><loc>https://curecurrent.com/trials/retrovirus-epidemiology-donor-study-i-reds-i-131773</loc></url>
<url><loc>https://curecurrent.com/trials/retrovirus-epidemiology-donor-study-ii-reds-ii-131774</loc></url>
<url><loc>https://curecurrent.com/trials/transfusion-safety-study-tss-131775</loc></url>
<url><loc>https://curecurrent.com/trials/anti-hiv-immunoglobulin-hivig-in-prevention-of-maternal-fetal-hiv-transmission-pediatric-actg-protocol-185-131776</loc></url>
<url><loc>https://curecurrent.com/trials/extended-release-naltrexone-to-treat-methamphetamine-dependence-in-men-who-have-sex-with-men-msm-131777</loc></url>
<url><loc>https://curecurrent.com/trials/d-c-f-taf-versus-cobi-boosted-drv-plus-ftc-tdf-in-hiv-1-infected-antiretroviral-treatment-naive-adults-131778</loc></url>
<url><loc>https://curecurrent.com/trials/efficacy-and-safety-study-of-optimized-background-antiretroviral-regimen-ob-in-combination-with-enfuvirtide-in-the-treat-131779</loc></url>
<url><loc>https://curecurrent.com/trials/a-study-to-evaluate-safety-acceptability-pharmacokinetics-and-ex-vivo-pharmacodynamics-of-tmc278-long-acting-formulation-131780</loc></url>
<url><loc>https://curecurrent.com/trials/transmission-reduction-intervention-project-131781</loc></url>
<url><loc>https://curecurrent.com/trials/a-non-inferiority-randomized-controlled-trial-to-evaluate-promoting-condom-use-among-msm-and-transgender-individuals-in-131782</loc></url>
<url><loc>https://curecurrent.com/trials/impaact-p1063-safety-and-effectiveness-of-atorvastatin-in-hiv-infected-children-and-adolescents-with-hyperlipidemia-131783</loc></url>
<url><loc>https://curecurrent.com/trials/eliciting-affect-in-teens-in-a-virtual-world-project-avatar-131784</loc></url>
<url><loc>https://curecurrent.com/trials/improving-nicotine-patch-adherence-among-latino-hiv-positive-smokers-131785</loc></url>
<url><loc>https://curecurrent.com/trials/effects-of-intensive-cart-during-acute-early-hiv-infection-131786</loc></url>
<url><loc>https://curecurrent.com/trials/clinical-trial-of-brain-penetrating-hiv-drugs-to-prevent-cognitive-impairment-in-china-131787</loc></url>
<url><loc>https://curecurrent.com/trials/a-post-marketing-survey-study-to-evaluate-the-safety-and-effectiveness-of-intelence-131788</loc></url>
<url><loc>https://curecurrent.com/trials/hiv-aids-severe-mental-illness-and-homelessness-131789</loc></url>
<url><loc>https://curecurrent.com/trials/effects-of-maternal-anti-hiv-treatment-on-infants-born-to-hiv-infected-women-131790</loc></url>
<url><loc>https://curecurrent.com/trials/tmc278-tidp6-c215-a-clinical-trial-in-treatment-naive-hiv-subjects-patients-comparing-tmc278-to-efavirenz-in-combination-131791</loc></url>
<url><loc>https://curecurrent.com/trials/mmr-vaccination-among-hiv-infected-adults-131792</loc></url>
<url><loc>https://curecurrent.com/trials/dutch-acute-hcv-in-hiv-study-dahhs-131793</loc></url>
<url><loc>https://curecurrent.com/trials/routine-use-of-antiretroviral-therapy-to-prevent-mother-to-child-hiv-transmission-in-the-kafue-district-of-zambia-131794</loc></url>
<url><loc>https://curecurrent.com/trials/prevention-of-transmission-of-sexually-transmitted-diseases-in-the-youth-through-effective-intervention-131795</loc></url>
<url><loc>https://curecurrent.com/trials/a-mixed-methods-approach-to-understanding-factors-associated-with-cervical-cancer-screening-utilization-among-low-income-131796</loc></url>
<url><loc>https://curecurrent.com/trials/tmc278-tidp6-c209-a-clinical-trial-in-treatment-naive-hiv-1-patients-comparing-tmc278-to-efavirenz-in-combination-with-t-131797</loc></url>
<url><loc>https://curecurrent.com/trials/urban-health-study-ii-131798</loc></url>
<url><loc>https://curecurrent.com/trials/use-of-a-nutritional-supplement-to-treat-diabetic-symptoms-in-hiv-infected-adults-131799</loc></url>
<url><loc>https://curecurrent.com/trials/the-effectiveness-of-a-counselling-intervention-on-the-uptake-of-hiv-care-services-among-hiv-infected-patients-in-uganda-131800</loc></url>
<url><loc>https://curecurrent.com/trials/penetration-and-compartimentation-of-hiv-131801</loc></url>
<url><loc>https://curecurrent.com/trials/effects-of-igf-i-in-hiv-metabolic-disease-131802</loc></url>
<url><loc>https://curecurrent.com/trials/ssat067-pk-of-atazanavir-cobicistat-and-darunavir-cobicistat-131803</loc></url>
<url><loc>https://curecurrent.com/trials/exploring-novel-mechanisms-of-vaccine-failure-laiv-pilot-study-131804</loc></url>
<url><loc>https://curecurrent.com/trials/diet-exercise-niacin-and-fenofibrate-to-reduce-heart-disease-risk-factors-in-individuals-with-hiv-lipodystrophy-or-dysli-131805</loc></url>
<url><loc>https://curecurrent.com/trials/rh-and-adolescents-131806</loc></url>
<url><loc>https://curecurrent.com/trials/manhattan-hiv-hepatology-brain-bank-131807</loc></url>
<url><loc>https://curecurrent.com/trials/como-cognition-study-with-hiv-patients-ctnpt-015-131808</loc></url>
<url><loc>https://curecurrent.com/trials/aids-associated-heart-disease-incidence-and-etiology-131809</loc></url>
<url><loc>https://curecurrent.com/trials/hiv-diversity-and-pathogenesis-in-donor-recipient-clusters-131810</loc></url>
<url><loc>https://curecurrent.com/trials/pulmonary-complications-of-hiv-infection-study-pacs-131811</loc></url>
<url><loc>https://curecurrent.com/trials/topiramate-to-reduce-heavy-drinking-in-hiv-positive-heavy-drinkers-131812</loc></url>
<url><loc>https://curecurrent.com/trials/hospital-visit-as-opportunity-for-prevention-and-engagement-for-hiv-infected-drug-users-131813</loc></url>
<url><loc>https://curecurrent.com/trials/studies-of-ocular-complications-of-aids-soca-ganciclovir-cidofovir-cmv-retinitis-trial-gccrt-131814</loc></url>
<url><loc>https://curecurrent.com/trials/sleep-and-cognition-after-atripla-to-stribild-switch-131815</loc></url>
<url><loc>https://curecurrent.com/trials/kshv-infection-in-blood-donors-from-texas-131816</loc></url>
<url><loc>https://curecurrent.com/trials/measurement-of-glomerular-filtration-rate-gfr-in-hiv-patients-single-center-study-comparing-the-accuracy-of-estimators-o-131817</loc></url>
<url><loc>https://curecurrent.com/trials/adherence-support-intervention-for-persons-living-with-hiv-aids-plwha-on-antiretroviral-therapy-art-in-estonia-131818</loc></url>
<url><loc>https://curecurrent.com/trials/use-of-rosuvastatin-in-hiv-infected-subjects-to-modulate-cardiovascular-risks-131819</loc></url>
<url><loc>https://curecurrent.com/trials/a-pilot-study-of-a-dendritic-cell-vaccine-in-hiv-1-infected-subjects-131820</loc></url>
<url><loc>https://curecurrent.com/trials/screening-for-tuberculosis-in-hiv-infected-patients-eligible-for-antiretroviral-treatment-131821</loc></url>
<url><loc>https://curecurrent.com/trials/smf-to-improve-performance-of-microscopy-for-the-diagnosis-of-ptb-in-a-high-hiv-prevalence-setting-131822</loc></url>
<url><loc>https://curecurrent.com/trials/utilization-of-hiv-clinical-services-in-rural-india-131823</loc></url>
<url><loc>https://curecurrent.com/trials/screening-for-hiv-associated-anal-cancer-131824</loc></url>
<url><loc>https://curecurrent.com/trials/a-study-of-invirase-saquinavir-ritonavir-in-hiv-infected-infants-and-children-131825</loc></url>
<url><loc>https://curecurrent.com/trials/observational-study-on-anti-tat-immune-response-in-hiv-1-infected-haart-treated-adult-subjects-131826</loc></url>
<url><loc>https://curecurrent.com/trials/observational-study-on-anti-tat-immune-response-in-hiv-1-infected-asymptomatic-adult-subjects-131827</loc></url>
<url><loc>https://curecurrent.com/trials/study-to-assess-the-seroprevalence-of-anti-tat-antibodies-in-hiv-infected-patients-131828</loc></url>
<url><loc>https://curecurrent.com/trials/early-hiv-therapy-in-patients-with-high-cd4-cell-counts-131829</loc></url>
<url><loc>https://curecurrent.com/trials/a-phase-i-safety-and-immunogenicity-preventive-vaccine-trial-based-on-the-hiv-1-tat-and-v2-deleted-env-proteins-iss-p-00-131830</loc></url>
<url><loc>https://curecurrent.com/trials/a-phase-il-of-a-therapeutic-recombinant-biologically-active-hiv-1-tat-protein-vaccine-in-hiv-infected-anti-tat-negative-131831</loc></url>
<url><loc>https://curecurrent.com/trials/immunogenicity-and-safety-trial-of-the-hiv-1-tat-vaccine-131832</loc></url>
<url><loc>https://curecurrent.com/trials/affect-management-for-early-adolescents-131833</loc></url>
<url><loc>https://curecurrent.com/trials/a-study-to-assess-cerebrospinal-fluid-inflammatory-markers-after-addition-of-maraviroc-to-monotherapy-darunavir-ritonavi-131834</loc></url>
<url><loc>https://curecurrent.com/trials/smoking-cessation-for-hiv-aids-patients-131835</loc></url>
<url><loc>https://curecurrent.com/trials/operational-assessment-of-point-of-care-diagnostics-in-primary-healthcare-clinics-131836</loc></url>
<url><loc>https://curecurrent.com/trials/home-based-partner-education-and-testing-hope-study-131837</loc></url>
<url><loc>https://curecurrent.com/trials/centralized-off-site-adherence-enhancement-program-131838</loc></url>
<url><loc>https://curecurrent.com/trials/hcv-hiv-coinfection-antiviral-therapy-and-fibrosis-131839</loc></url>
<url><loc>https://curecurrent.com/trials/backup-with-combivir-or-single-dose-sd-truvada-in-order-to-avoid-non-nucleoside-reverse-transcriptase-inhibitor-nnrti-re-131840</loc></url>
<url><loc>https://curecurrent.com/trials/comparison-of-cervical-cancer-screening-tests-in-hiv-infected-women-in-lusaka-zambia-131841</loc></url>
<url><loc>https://curecurrent.com/trials/remune-amplivax-ir103-hiv-aids-phase-iii-safety-efficacy-study-131842</loc></url>
<url><loc>https://curecurrent.com/trials/remune-hiv-aids-vaccine-phase-ii-pediatric-safety-efficacy-clinical-study-131843</loc></url>
<url><loc>https://curecurrent.com/trials/estimating-the-global-need-for-palliative-care-for-children-131844</loc></url>
<url><loc>https://curecurrent.com/trials/abacavir-and-lamivudine-pk-in-children-131845</loc></url>
<url><loc>https://curecurrent.com/trials/intrauterine-insemination-in-hiv-discordant-couples-131846</loc></url>
<url><loc>https://curecurrent.com/trials/progress-pediatric-study-131847</loc></url>
<url><loc>https://curecurrent.com/trials/maternal-fetal-cd4-microchimerism-in-hiv-exposed-newborns-after-spontaneous-delivery-and-cesarean-section-131848</loc></url>
<url><loc>https://curecurrent.com/trials/efficacy-of-tenofovir-and-emtricitabine-in-arv-naive-patients-with-hiv-hbv-co-infection-131849</loc></url>
<url><loc>https://curecurrent.com/trials/efficacy-of-intrathecal-administration-of-liposomal-amphotericin-b-in-cryptococcal-meningitis-131850</loc></url>
<url><loc>https://curecurrent.com/trials/investigational-vaccine-for-the-prevention-of-disseminated-tuberculosis-in-hiv-infected-people-131851</loc></url>
<url><loc>https://curecurrent.com/trials/cardiac-autonomic-control-in-children-of-hiv-positive-mothers-131852</loc></url>
<url><loc>https://curecurrent.com/trials/development-of-a-family-intervention-to-address-drug-use-and-hiv-in-vietnam-131853</loc></url>
<url><loc>https://curecurrent.com/trials/aids-associated-cardiomyopathy-131854</loc></url>
<url><loc>https://curecurrent.com/trials/hiv-associated-heart-disease-131855</loc></url>
<url><loc>https://curecurrent.com/trials/a-phase-i-study-to-evaluate-the-safety-and-immunogenicity-of-heterologous-boost-immunizations-with-mva-cmdr-131856</loc></url>
<url><loc>https://curecurrent.com/trials/safety-and-efficacy-of-cobicistat-boosted-atazanavir-compared-to-ritonavir-boosted-atazanavir-in-combination-with-emtric-131857</loc></url>
<url><loc>https://curecurrent.com/trials/t-20-plus-a-selected-anti-hiv-treatment-in-hiv-infected-children-and-adolescents-131858</loc></url>
<url><loc>https://curecurrent.com/trials/eban-ii-intervention-for-hiv-sero-discordant-couples-131859</loc></url>
<url><loc>https://curecurrent.com/trials/effect-of-bacterial-vaginosis-on-hiv-susceptibility-and-female-genital-immunology-131860</loc></url>
<url><loc>https://curecurrent.com/trials/the-effect-of-hiv-tat-protein-on-hcv-replication-in-an-in-vitro-model-system-131861</loc></url>
<url><loc>https://curecurrent.com/trials/evaluation-on-seropositive-patients-of-a-synthetic-vaccine-targeting-the-hiv-tat-protein-131862</loc></url>
<url><loc>https://curecurrent.com/trials/pre-exposure-prophylaxis-adherence-intervention-for-msm-131863</loc></url>
<url><loc>https://curecurrent.com/trials/immune-and-viral-outcomes-of-hiv-1-therapy-interruption-131864</loc></url>
<url><loc>https://curecurrent.com/trials/effectiveness-of-mobile-phone-technology-on-adherence-and-treatment-outcomes-among-hiv-positive-patients-on-art-131865</loc></url>
<url><loc>https://curecurrent.com/trials/truvada-plus-raltegravir-for-nonoccupational-post-exposure-prophylaxis-npep-131866</loc></url>
<url><loc>https://curecurrent.com/trials/n-acetylcysteine-to-reduce-oxidative-stress-and-improve-endothelial-function-in-hiv-infected-older-adults-131867</loc></url>
<url><loc>https://curecurrent.com/trials/switch-to-darunavir-r-maraviroc-quaque-die-in-patients-with-r5-tropism-by-viral-dna-genotyping-gusta-131868</loc></url>
<url><loc>https://curecurrent.com/trials/immune-reconstitution-in-hiv-disease-irehiv-131869</loc></url>
<url><loc>https://curecurrent.com/trials/minocycline-for-the-treatment-of-decreased-mental-function-in-hiv-infected-adults-131870</loc></url>
<url><loc>https://curecurrent.com/trials/pilot-study-of-a-raltegravir-based-nrti-sparing-regimen-131871</loc></url>
<url><loc>https://curecurrent.com/trials/pharmacokinetic-pk-study-of-single-dose-rosuvastatin-and-tipranavir-ritonavir-in-healthy-subjects-131872</loc></url>
<url><loc>https://curecurrent.com/trials/endothelial-function-lipoproteins-and-inflammation-with-low-hdl-cholesterol-in-hiv-er-niacin-versus-fenofibrate-131873</loc></url>
<url><loc>https://curecurrent.com/trials/zidovudine-plus-interleukin-2-and-ganciclovir-in-treating-patients-with-aids-related-primary-central-nervous-system-lymp-131874</loc></url>
<url><loc>https://curecurrent.com/trials/peripheral-stem-cell-transplantation-followed-by-infusion-of-white-blood-cells-in-treating-patients-with-aids-related-ly-131875</loc></url>
<url><loc>https://curecurrent.com/trials/chemotherapy-followed-by-peripheral-stem-cell-transplantation-in-treating-patients-with-recurrent-or-refractory-aids-rel-131876</loc></url>
<url><loc>https://curecurrent.com/trials/hiv-prevention-among-latino-msm-evaluation-of-a-locally-developed-intervention-131877</loc></url>
<url><loc>https://curecurrent.com/trials/dose-optimisation-of-stavudine-for-the-treatment-of-hiv-infection-131878</loc></url>
<url><loc>https://curecurrent.com/trials/an-enhanced-adherence-support-programme-for-highly-active-antiretroviral-therapy-haart-131879</loc></url>
<url><loc>https://curecurrent.com/trials/effect-of-haart-vs-statin-treatment-on-endothelial-function-and-inflammation-coagulation-131880</loc></url>
<url><loc>https://curecurrent.com/trials/safety-and-effectiveness-study-of-a-candidate-vaginal-microbicide-for-prevention-of-hiv-131881</loc></url>
<url><loc>https://curecurrent.com/trials/peripheral-arterial-insufficiency-associated-with-hiv-aids-131882</loc></url>
<url><loc>https://curecurrent.com/trials/safety-and-efficacy-study-of-daclatasvir-bms-790052-plus-pegylated-interferon-alfa-2a-and-ribavirin-in-patients-coinfect-131883</loc></url>
<url><loc>https://curecurrent.com/trials/addressing-discrimination-and-mistrust-among-black-men-phase-iii-131884</loc></url>
<url><loc>https://curecurrent.com/trials/maternal-infant-peripartum-nvp-versus-infant-only-peripartum-nvp-or-maternal-lpv-r-in-addition-to-standard-zdv-prophylax-131885</loc></url>
<url><loc>https://curecurrent.com/trials/comparison-of-tenofovir-vaginal-gel-and-film-formulations-131886</loc></url>
<url><loc>https://curecurrent.com/trials/leptin-for-abnormal-lipid-kinetics-in-hiv-lipodystrophy-syndrome-131887</loc></url>
<url><loc>https://curecurrent.com/trials/peer-education-program-for-hiv-aids-related-sexual-behaviors-of-secondary-school-students-131888</loc></url>
<url><loc>https://curecurrent.com/trials/4-consecutive-days-on-treatment-followed-by-3-days-off-treatment-in-hiv-patients-131889</loc></url>
<url><loc>https://curecurrent.com/trials/safety-and-immunogenicity-study-of-a-dna-vaccine-combined-with-protein-vaccine-against-hiv-aids-131890</loc></url>
<url><loc>https://curecurrent.com/trials/oral-human-papillomavirus-infection-in-hiv-infected-men-131891</loc></url>
<url><loc>https://curecurrent.com/trials/viral-load-determination-and-biomarkers-of-high-risk-human-papillomavirus-hpv-types-in-hiv-positive-men-131892</loc></url>
<url><loc>https://curecurrent.com/trials/march-central-nervous-system-substudy-131893</loc></url>
<url><loc>https://curecurrent.com/trials/a-phase-2b-evaluation-of-daclatasvir-sofosbuvir-in-non-cirrhotic-treatment-naive-subjects-with-genotype-1-2-3-and-4-chro-131894</loc></url>
<url><loc>https://curecurrent.com/trials/march-renal-substudy-131895</loc></url>
<url><loc>https://curecurrent.com/trials/maraviroc-switch-collaborative-study-131896</loc></url>
<url><loc>https://curecurrent.com/trials/daily-co-trimoxazole-prophylaxis-to-prevent-malaria-in-pregnancy-131897</loc></url>
<url><loc>https://curecurrent.com/trials/cardiovascular-risk-in-hiv-patients-on-antiretroviral-therapy-therapy-the-mheart-study-131898</loc></url>
<url><loc>https://curecurrent.com/trials/improving-consent-and-survey-procedures-for-young-msm-in-web-based-hiv-prevention-131899</loc></url>
<url><loc>https://curecurrent.com/trials/study-of-pro-140-by-subcutaneous-administration-in-adult-subjects-with-hiv-1-infection-131900</loc></url>
<url><loc>https://curecurrent.com/trials/comparative-trial-of-maraviroc-versus-emtricitabine-tenofovir-both-with-darunavir-ritonavir-in-antiretroviral-naive-pati-131901</loc></url>
<url><loc>https://curecurrent.com/trials/expansion-to-interdisciplinary-hiv-prevention-in-women-131902</loc></url>
<url><loc>https://curecurrent.com/trials/lactate-metabolism-study-in-hiv-infected-persons-131903</loc></url>
<url><loc>https://curecurrent.com/trials/the-effects-of-anabolic-steroids-and-protease-inhibitors-on-people-living-with-hiv-aids-131904</loc></url>
<url><loc>https://curecurrent.com/trials/gut-associated-lymphatic-tissue-galt-in-hiv-human-immunodeficiency-virus-infected-patients-131905</loc></url>
<url><loc>https://curecurrent.com/trials/impact-of-antiretroviral-therapy-on-metabolic-skeletal-and-cardiovascular-parameters-131906</loc></url>
<url><loc>https://curecurrent.com/trials/phase-i-one-month-safety-pk-pd-and-acceptability-study-of-ivr-releasing-tfv-and-lng-or-tfv-alone-131907</loc></url>
<url><loc>https://curecurrent.com/trials/study-to-evaluate-switching-from-regimens-consisting-of-a-nonnucleoside-reverse-transcriptase-inhibitor-plus-emtricitabi-131908</loc></url>
<url><loc>https://curecurrent.com/trials/a-phase-i-multiple-dose-pharmacokinetic-study-of-nevirapine-extended-release-xr-in-hiv-1-infected-children-131909</loc></url>
<url><loc>https://curecurrent.com/trials/a-study-to-assess-dolutegravir-in-hiv-infected-subjects-with-treatment-failure-on-an-integrase-inhibitor-containing-regi-131910</loc></url>
<url><loc>https://curecurrent.com/trials/effect-of-rifampin-rif-on-the-pharmacokinetics-pk-of-oral-cabotegravir-cab-in-healthy-subjects-131911</loc></url>
<url><loc>https://curecurrent.com/trials/effect-of-community-social-mobilization-for-the-prevention-of-hiv-in-young-south-african-women-131912</loc></url>
<url><loc>https://curecurrent.com/trials/depression-amongst-hiv-positive-patients-in-lilongwe-131913</loc></url>
<url><loc>https://curecurrent.com/trials/addition-of-ezetimibe-ezetrol-to-ongoing-therapy-with-rosuvastatin-crestor-in-hiv-positive-patients-not-reaching-cholest-131914</loc></url>
<url><loc>https://curecurrent.com/trials/changes-in-triglyceride-and-other-lipids-levels-of-fats-found-in-blood-when-taking-darunavir-compared-to-atazanavir-in-h-131915</loc></url>
<url><loc>https://curecurrent.com/trials/renal-and-bone-outcome-after-switching-tenofovir-to-different-antiretroviral-strategies-131916</loc></url>
<url><loc>https://curecurrent.com/trials/pilot-study-of-maraviroc-raltegravir-for-naive-hiv-1-patients-131917</loc></url>
<url><loc>https://curecurrent.com/trials/safety-and-antiviral-study-of-ach-126-443-beta-l-fd4c-in-the-treatment-of-adults-with-hiv-infection-and-modestly-detecta-131918</loc></url>
<url><loc>https://curecurrent.com/trials/tuberculosis-in-a-multiethnic-inner-city-population-131919</loc></url>
<url><loc>https://curecurrent.com/trials/antiretroviral-therapy-and-inflammatory-and-coagulation-biomarkers-imacs-study-131920</loc></url>
<url><loc>https://curecurrent.com/trials/mother-infant-retention-for-health-mir4health-131921</loc></url>
<url><loc>https://curecurrent.com/trials/pharmacokinetic-interactions-between-dmpa-and-lpv-r-among-hiv-infected-women-131922</loc></url>
<url><loc>https://curecurrent.com/trials/cidofovir-in-treating-hiv-infected-patients-with-high-grade-squamous-intraepithelial-lesions-of-the-skin-near-the-anus-131923</loc></url>
<url><loc>https://curecurrent.com/trials/vicriviroc-in-hiv-r5-x4-treatment-experienced-subjects-study-p05057am5-completed-131924</loc></url>
<url><loc>https://curecurrent.com/trials/pharmacokinetics-safety-and-tolerability-study-of-abacavir-dolutegravir-lamivudine-fixed-dose-combination-tablets-in-hea-131925</loc></url>
<url><loc>https://curecurrent.com/trials/weltel-retain-promoting-engagement-in-pre-art-hiv-care-through-sms-131926</loc></url>
<url><loc>https://curecurrent.com/trials/bryostatin-1-effect-on-hiv-1-latency-and-reservoir-in-hiv-1-infected-patients-receiving-antiretroviral-treatment-131927</loc></url>
<url><loc>https://curecurrent.com/trials/transfusion-infections-pediatric-prospective-study-tripps-131928</loc></url>
<url><loc>https://curecurrent.com/trials/influenza-vaccine-in-hiv-study-131929</loc></url>
<url><loc>https://curecurrent.com/trials/feasibility-of-measuring-immune-resp-activation-in-foreskin-mucosa-in-hiv-uncircumcised-high-hiv-risk-msm-lima-peru-131930</loc></url>
<url><loc>https://curecurrent.com/trials/veterans-living-with-hiv-aids-a-pilot-study-examining-risk-factors-associated-with-self-directed-violence-131931</loc></url>
<url><loc>https://curecurrent.com/trials/the-canadian-hiv-quit-smoking-trial-tackling-the-co-morbidities-of-depression-and-cardiovascular-disease-in-hiv-smokers-131932</loc></url>
<url><loc>https://curecurrent.com/trials/t1-mapping-in-hiv-patients-with-high-and-low-cd4-cell-counts-131933</loc></url>
<url><loc>https://curecurrent.com/trials/a-safety-study-of-dapivirine-tmc120-vaginal-microbicide-gel-in-south-africa-131934</loc></url>
<url><loc>https://curecurrent.com/trials/pediatric-enhanced-surveillance-study-131935</loc></url>
<url><loc>https://curecurrent.com/trials/evaluating-an-exercise-program-to-reduce-cardiovascular-risk-factors-in-children-infected-with-hiv-131936</loc></url>
<url><loc>https://curecurrent.com/trials/study-to-evaluate-switching-from-regimens-consisting-of-a-ritonavir-boosted-protease-inhibitor-pi-and-two-nucleoside-rev-131937</loc></url>
<url><loc>https://curecurrent.com/trials/safety-and-efficacy-of-an-investigational-drug-in-human-immunodeficiency-virus-hiv-infected-patients-failing-current-ant-131938</loc></url>
<url><loc>https://curecurrent.com/trials/a-pilot-study-assessing-the-integrase-inhibitor-gsk1349572-in-hiv-infected-persons-with-virus-resistant-to-raltegravir-131939</loc></url>
<url><loc>https://curecurrent.com/trials/differences-in-blood-levels-of-lopinavir-ritonavir-in-hiv-infected-men-and-women-131940</loc></url>
<url><loc>https://curecurrent.com/trials/clinical-implications-of-hiv-low-level-viremia-at-times-of-highly-active-antiretroviral-treatment-regimens-131941</loc></url>
<url><loc>https://curecurrent.com/trials/hiv-prevention-among-substance-abusing-smi-131942</loc></url>
<url><loc>https://curecurrent.com/trials/a-comparison-of-immediate-treatment-of-cin1-with-cryotherapy-and-12-month-cytology-follow-up-in-hiv-seropositive-women-131943</loc></url>
<url><loc>https://curecurrent.com/trials/assessing-short-and-long-term-compliance-with-caloric-intake-in-hiv-positive-women-taking-complera-131944</loc></url>
<url><loc>https://curecurrent.com/trials/healthy-beginning-initiative-131945</loc></url>
<url><loc>https://curecurrent.com/trials/hiv-discordant-couple-intrauterine-insemination-131946</loc></url>
<url><loc>https://curecurrent.com/trials/a-study-to-assess-the-safety-and-effectiveness-of-darunavir-for-treating-human-immunodeficiency-virus-type-i-hiv-1-infec-131947</loc></url>
<url><loc>https://curecurrent.com/trials/a-study-on-the-safety-and-effectiveness-of-rilpivirine-hydrochloride-edurant-among-adult-filipino-patients-with-human-im-131948</loc></url>
<url><loc>https://curecurrent.com/trials/the-role-of-genital-warts-in-hiv-acquisition-in-peru-131949</loc></url>
<url><loc>https://curecurrent.com/trials/pediatric-expanded-access-program-oral-solution-0831-908-131950</loc></url>
<url><loc>https://curecurrent.com/trials/multicentre-study-to-assess-changes-in-bone-mineral-density-of-the-switch-from-protease-inhibitors-to-dolutegravir-in-hi-131951</loc></url>
<url><loc>https://curecurrent.com/trials/valganciclovir-in-treating-patients-with-classic-non-hiv-associated-kaposi-s-sarcoma-131952</loc></url>
<url><loc>https://curecurrent.com/trials/study-of-integrating-antiretroviral-therapy-with-methadone-treatment-for-people-who-inject-drugs-131953</loc></url>
<url><loc>https://curecurrent.com/trials/optimizing-kidney-transplant-informed-consent-131954</loc></url>
<url><loc>https://curecurrent.com/trials/immune-activation-in-hiv-1-infected-patients-under-antiretroviral-treatment-131955</loc></url>
<url><loc>https://curecurrent.com/trials/immune-response-after-booster-vaccination-in-hiv-infected-patients-who-received-rabies-primary-vaccination-131956</loc></url>
<url><loc>https://curecurrent.com/trials/deep-vein-thrombosis-treatment-with-the-oral-direct-factor-xa-inhibitor-rivaroxaban-in-patients-using-a-strong-cyp-3a4-i-131957</loc></url>
<url><loc>https://curecurrent.com/trials/nevirapine-dosing-in-neonates-for-prophylaxis-of-mother-to-child-transmission-mtct-of-hiv-infection-131958</loc></url>
<url><loc>https://curecurrent.com/trials/effect-of-a-micro-finance-based-intervention-for-the-prevention-of-intimate-partner-violence-and-hiv-131959</loc></url>
<url><loc>https://curecurrent.com/trials/studies-of-the-ocular-complications-of-aids-soca-hpmpc-peripheral-cmv-retinitis-trial-hpcrt-131960</loc></url>
<url><loc>https://curecurrent.com/trials/studies-of-the-ocular-complications-of-aids-soca-monoclonal-antibody-cmv-retinitis-trial-macrt-131961</loc></url>
<url><loc>https://curecurrent.com/trials/anal-hpv-infection-and-abnormal-cytology-in-hiv-infected-women-131962</loc></url>
<url><loc>https://curecurrent.com/trials/bioequivalence-study-between-lamivudine-formulations-in-the-form-of-coated-tablet-of-150-mg-in-healthy-volunteers-131963</loc></url>
<url><loc>https://curecurrent.com/trials/evaluation-of-3tc-or-ftc-mono-therapy-compared-to-continuing-haart-as-a-bridging-strategy-131964</loc></url>
<url><loc>https://curecurrent.com/trials/linking-hospitalized-injection-drug-users-to-buprenorphine-131965</loc></url>
<url><loc>https://curecurrent.com/trials/hepatic-safety-of-currently-used-antiretroviral-regimens-in-patients-with-chronic-hepatitis-under-real-life-conditions-131966</loc></url>
<url><loc>https://curecurrent.com/trials/study-to-evaluate-the-safety-and-efficacy-of-stribild-versus-atripla-in-human-immunodeficiency-virus-type-1-hiv-1-infect-131967</loc></url>
<url><loc>https://curecurrent.com/trials/study-to-evaluate-the-safety-and-efficacy-of-stribild-versus-ritonavir-boosted-atazanavir-plus-truvada-in-human-immunode-131968</loc></url>
<url><loc>https://curecurrent.com/trials/randomized-clinical-trial-to-assess-the-efficacy-and-safety-of-concomitant-use-of-rifampicin-and-efavirenz-600-x-800mg-131969</loc></url>
<url><loc>https://curecurrent.com/trials/safety-and-acceptability-of-cabotegravir-in-hiv-uninfected-women-in-kwazulu-natal-south-africa-131970</loc></url>
<url><loc>https://curecurrent.com/trials/human-immune-responses-toward-hiv-1-envelope-antigens-131971</loc></url>
<url><loc>https://curecurrent.com/trials/enhanced-provision-of-male-circumcision-mc-for-hiv-prevention-rakai-uganda-131972</loc></url>
<url><loc>https://curecurrent.com/trials/traditional-cam-therapy-in-the-treatment-of-hiv-aids-131973</loc></url>
<url><loc>https://curecurrent.com/trials/wand-study-a-study-to-evaluate-fuzeon-enfuvirtide-administered-by-a-needle-free-injection-device-in-patients-with-hiv-131974</loc></url>
<url><loc>https://curecurrent.com/trials/boss-study-a-study-of-fuzeon-using-the-needle-free-biojector-2000-in-patients-with-hiv-1-infection-131975</loc></url>
<url><loc>https://curecurrent.com/trials/pharmacokinetics-and-pharmacodynamics-of-an-anti-hiv-drug-in-israeli-ethiopian-and-non-ethiopian-populations-131976</loc></url>
<url><loc>https://curecurrent.com/trials/impact-of-pre-art-blood-cd4-t-cell-level-on-the-rectal-reservoir-in-long-term-hiv-1-treated-men-131977</loc></url>
<url><loc>https://curecurrent.com/trials/rapid-hiv-testing-program-in-the-emergency-department-131978</loc></url>
<url><loc>https://curecurrent.com/trials/three-dose-regimen-of-mrkad5-6-trigene-v526-in-healthy-adults-v526-001-completed-131979</loc></url>
<url><loc>https://curecurrent.com/trials/management-of-human-immunodeficiency-virus-1-hiv-1-participants-treated-with-antiretroviral-arv-combination-therapy-incl-131980</loc></url>
<url><loc>https://curecurrent.com/trials/reducing-unsafe-alcohol-use-in-hiv-positive-individuals-131981</loc></url>
<url><loc>https://curecurrent.com/trials/a-phase-3-study-to-evaluate-combination-therapy-with-daclatasvir-and-sofosbuvir-in-the-treatment-of-hiv-and-hepatitis-c-131982</loc></url>
<url><loc>https://curecurrent.com/trials/cogstim-a-pilot-study-cognitive-rehabilitation-management-of-hiv-1-mild-cognitively-impaired-patients-controlled-with-an-131983</loc></url>
<url><loc>https://curecurrent.com/trials/bioequivalence-study-of-two-formulations-with-the-association-of-tenofovir-300-mg-and-emtricitabine-200-mg-131984</loc></url>
<url><loc>https://curecurrent.com/trials/studies-of-the-ocular-complications-of-aids-soca-foscarnet-ganciclovir-cmv-retinitis-trial-fgcrt-131985</loc></url>
<url><loc>https://curecurrent.com/trials/a-study-to-monitor-patients-with-primary-or-early-hiv-infection-131986</loc></url>
<url><loc>https://curecurrent.com/trials/the-biology-of-hiv-transmission-131987</loc></url>
<url><loc>https://curecurrent.com/trials/positive-lifestyles-using-safety-131988</loc></url>
<url><loc>https://curecurrent.com/trials/study-to-determine-impact-of-feeding-buddies-on-adherence-to-who-pmtct-guidelines-in-south-africa-131989</loc></url>
<url><loc>https://curecurrent.com/trials/safety-and-efficacy-study-of-non-surgical-mc-device-for-adolescent-male-population-including-contraindicated-subjects-131990</loc></url>
<url><loc>https://curecurrent.com/trials/positive-change-agents-program-tanzania-evaluation-131991</loc></url>
<url><loc>https://curecurrent.com/trials/effect-of-hiv-infection-and-highly-active-antiretroviral-treatment-haart-on-bone-homeostasis-131992</loc></url>
<url><loc>https://curecurrent.com/trials/adhepta-study-adherence-questionnaire-in-hepatitis-c-131993</loc></url>
<url><loc>https://curecurrent.com/trials/diarrhea-and-bivalent-oral-polio-vaccine-immunity-131994</loc></url>
<url><loc>https://curecurrent.com/trials/emotional-disclosure-in-hiv-131995</loc></url>
<url><loc>https://curecurrent.com/trials/rapid-hiv-testing-and-counseling-in-drug-abuse-treatment-131996</loc></url>
<url><loc>https://curecurrent.com/trials/evaluation-of-an-innovative-tuberculosis-diagnostic-test-131997</loc></url>
<url><loc>https://curecurrent.com/trials/venue-based-couples-coop-in-south-africa-131998</loc></url>
<url><loc>https://curecurrent.com/trials/implementation-of-the-pre-exposure-prophylaxis-prep-to-hiv-a-demonstrative-project-131999</loc></url>
<url><loc>https://curecurrent.com/trials/cervical-cancer-screening-in-hiv-positive-and-negative-women-in-cambodia-132000</loc></url>
<url><loc>https://curecurrent.com/trials/investigation-of-v520-in-an-hiv-vaccine-proof-of-concept-study-v520-023-132001</loc></url>
<url><loc>https://curecurrent.com/trials/gallium-nitrate-in-treating-patients-with-aids-related-non-hodgkin-s-lymphoma-132002</loc></url>
<url><loc>https://curecurrent.com/trials/comparative-trial-of-antidepressant-treatment-models-in-hiv-care-in-uganda-132003</loc></url>
<url><loc>https://curecurrent.com/trials/human-papilloma-virus-infection-in-hiv-positive-indian-men-who-have-sex-with-men-132004</loc></url>
<url><loc>https://curecurrent.com/trials/development-of-method-of-fructose-identification-in-urine-to-detect-the-viral-infection-132005</loc></url>
<url><loc>https://curecurrent.com/trials/hiv-1-vaccine-test-in-uninfected-adult-volunteers-132006</loc></url>
<url><loc>https://curecurrent.com/trials/observational-study-of-antiretroviral-arv-response-in-a-cohort-of-african-children-using-viral-load-monitoring-132007</loc></url>
<url><loc>https://curecurrent.com/trials/assessment-of-dolutegravir-removed-by-hemodialysis-in-hiv-infected-patients-with-end-stage-renal-disease-132008</loc></url>
<url><loc>https://curecurrent.com/trials/relationship-between-hiv-1-subtype-and-arv-response-132009</loc></url>
<url><loc>https://curecurrent.com/trials/safety-and-immunogenicity-of-mva85a-prime-and-bacille-calmette-guerin-boost-vaccination-132010</loc></url>
<url><loc>https://curecurrent.com/trials/towards-hiv-functional-cure-132011</loc></url>
<url><loc>https://curecurrent.com/trials/being-responsible-for-ourselves-hiv-risk-reduction-for-black-msm-132012</loc></url>
<url><loc>https://curecurrent.com/trials/impact-of-an-antibiotic-rifaximin-on-liver-scarring-in-hiv-infected-patients-with-liver-disease-132013</loc></url>
<url><loc>https://curecurrent.com/trials/vicriviroc-in-hiv-treatment-experienced-subjects-study-p04405am5-132014</loc></url>
<url><loc>https://curecurrent.com/trials/effect-of-hiv-std-risk-reduction-program-on-south-african-adolescents-132015</loc></url>
<url><loc>https://curecurrent.com/trials/pneumonia-vaccine-in-aging-hiv-positive-individuals-132016</loc></url>
<url><loc>https://curecurrent.com/trials/effects-of-dolutegravir-based-regimen-on-hiv-1-reservoir-and-immune-activation-132017</loc></url>
<url><loc>https://curecurrent.com/trials/microboosting-of-atazanavir-300-mg-with-50-mg-versus-100mg-ritonavir-daily-in-hiv-infected-patients-a-pharmacokinetic-st-132018</loc></url>
<url><loc>https://curecurrent.com/trials/retrieve-reverse-transcriptase-inhibitor-hiv-practice-132019</loc></url>
<url><loc>https://curecurrent.com/trials/patient-retention-in-hiv-medical-care-in-a-primary-care-practice-in-australia-132020</loc></url>
<url><loc>https://curecurrent.com/trials/the-role-of-multivitamins-in-pediatric-hiv-management-in-nigeria-132021</loc></url>
<url><loc>https://curecurrent.com/trials/pilot-study-of-text-message-reminders-to-improve-hiv-medication-adherence-in-botswana-132022</loc></url>
<url><loc>https://curecurrent.com/trials/studies-of-the-ocular-complications-of-aids-soca-cytomegalovirus-retinitis-retreatment-trial-crrt-132023</loc></url>
<url><loc>https://curecurrent.com/trials/the-study-of-gut-associated-lymphocytes-in-hiv-and-hcv-hiv-co-infected-patients-132024</loc></url>
<url><loc>https://curecurrent.com/trials/safety-and-pharmacokinetics-of-dapivirine-maraviroc-vaginal-ring-132025</loc></url>
<url><loc>https://curecurrent.com/trials/a-south-african-pilot-worksite-parenting-program-to-prevent-hiv-among-adolescents-132026</loc></url>
<url><loc>https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-an-investigational-drug-in-hiv-infected-patients-0518-004-completed-132027</loc></url>
<url><loc>https://curecurrent.com/trials/study-to-determine-the-effect-of-efavirenz-on-the-ecg-qtcf-interval-in-healthy-subjects-132028</loc></url>
<url><loc>https://curecurrent.com/trials/induction-maintenance-of-lopinavir-r-in-hiv-infected-subjects-132029</loc></url>
<url><loc>https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-raltegravir-mk0518-in-hiv-infected-patients-failing-current-antiretrovira-132030</loc></url>
<url><loc>https://curecurrent.com/trials/comparison-of-plasma-smartplasma-for-human-immunodeficiency-virus-hiv-and-hepatitis-c-virus-hcv-antibody-testing-132031</loc></url>
<url><loc>https://curecurrent.com/trials/omega-3-supplementation-in-hiv-patients-with-therapeutic-lifestyle-change-diet-132032</loc></url>
<url><loc>https://curecurrent.com/trials/dolutegravir-rilpivirine-switch-study-doriss-132033</loc></url>
<url><loc>https://curecurrent.com/trials/cellulose-sulfate-and-hiv-transmission-among-women-132034</loc></url>
<url><loc>https://curecurrent.com/trials/rectal-microbicide-safety-and-acceptability-trial-of-topically-applied-tenofovir-compared-with-oral-tablet-132035</loc></url>
<url><loc>https://curecurrent.com/trials/hiv-posterior-cheek-enlargement-132036</loc></url>
<url><loc>https://curecurrent.com/trials/hiv-sti-prevention-for-adolescents-with-substance-use-disorders-in-treatment-132037</loc></url>
<url><loc>https://curecurrent.com/trials/safety-and-immunogenicity-study-of-sev-g-np-hiv-vaccine-administered-intranasally-and-ad35-grin-hiv-vaccine-given-intram-132038</loc></url>
<url><loc>https://curecurrent.com/trials/impact-of-hyperbilirubinemia-among-hiv-patients-treated-with-atazanavir-132039</loc></url>
<url><loc>https://curecurrent.com/trials/platelets-study-influence-of-the-antiretroviral-treatment-on-the-platelet-physiology-during-hiv-infection-132040</loc></url>
<url><loc>https://curecurrent.com/trials/juvenile-offender-hiv-prevention-and-drug-abuse-services-132041</loc></url>
<url><loc>https://curecurrent.com/trials/investigation-of-v520-in-a-hiv-vaccine-dose-refinement-study-v520-027-terminated-132042</loc></url>
<url><loc>https://curecurrent.com/trials/energy-expenditure-of-people-living-with-hiv-aids-132043</loc></url>
<url><loc>https://curecurrent.com/trials/ibrutinib-in-treating-relapsed-or-refractory-b-cell-non-hodgkin-lymphoma-in-patients-with-hiv-infection-132044</loc></url>
<url><loc>https://curecurrent.com/trials/the-effect-of-protease-inhibitors-on-the-pharmacokinetics-of-oral-norethindrone-contraception-132045</loc></url>
<url><loc>https://curecurrent.com/trials/study-of-nuvaring-acceptability-adherence-and-biological-effects-among-hiv-negative-women-in-kenya-132046</loc></url>
<url><loc>https://curecurrent.com/trials/effect-of-omega-3-fatty-acids-on-oxidative-stress-in-hiv-seropositive-patients-132047</loc></url>
<url><loc>https://curecurrent.com/trials/text-messaging-to-improve-hiv-testing-among-young-women-in-kenya-132048</loc></url>
<url><loc>https://curecurrent.com/trials/evaluation-of-the-dpp-hiv-1-2-test-and-the-hiv-1-2-stat-pak-test-using-oral-fluid-132049</loc></url>
<url><loc>https://curecurrent.com/trials/tripterygium-wilfordii-hook-f-twhf-treatment-for-immune-non-responders-with-hiv-1-infection-132050</loc></url>
<url><loc>https://curecurrent.com/trials/efavirenz-versus-rilpivirine-on-vascular-function-inflammation-and-oxidative-stress-132051</loc></url>
<url><loc>https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-adding-enfuvirtide-to-oral-highly-active-antiretroviral-therapy-haart-in-132052</loc></url>
<url><loc>https://curecurrent.com/trials/analysis-of-host-genetic-factors-in-the-occurrence-of-anemia-and-on-the-virological-response-to-a-peg-interferon-ribavir-132053</loc></url>
<url><loc>https://curecurrent.com/trials/impaact-p1058a-pharmacokinetic-effects-of-new-antiretroviral-drugs-on-children-adolescents-and-young-adults-132054</loc></url>
<url><loc>https://curecurrent.com/trials/immune-response-to-pneumococcal-vaccination-in-hiv-infected-individuals-132055</loc></url>
<url><loc>https://curecurrent.com/trials/hepatic-safety-of-eviplera-in-hiv-hepatitis-c-hcv-coinfected-patients-without-hcv-treatment-in-the-the-hepavir-hepatic-s-132056</loc></url>
<url><loc>https://curecurrent.com/trials/improving-diagnosis-of-tuberculosis-in-hiv-infected-children-in-asia-cambodia-vietnam-and-africa-burkina-faso-cameroon-132057</loc></url>
<url><loc>https://curecurrent.com/trials/optimizing-antiretroviral-therapy-in-hiv-infected-children-and-adolescents-132058</loc></url>
<url><loc>https://curecurrent.com/trials/outcomes-of-hiv-infected-individuals-after-ten-years-on-antiretroviral-treatment-132059</loc></url>
<url><loc>https://curecurrent.com/trials/prevalence-of-hiv-associated-neurocognitive-disorders-hand-in-a-school-of-medicine-hiv-aids-outpatient-clinic-132060</loc></url>
<url><loc>https://curecurrent.com/trials/influence-of-cytochrome-p2b6-on-efavirenz-dose-in-hiv-infected-thai-patients-132061</loc></url>
<url><loc>https://curecurrent.com/trials/raltegravir-lopinavir-ritonavir-or-emtricitabine-tenofovir-for-hiv-treatment-naive-subjects-132062</loc></url>
<url><loc>https://curecurrent.com/trials/status-of-chronic-liver-disease-in-hepatitis-c-virus-hcv-patients-coinfected-with-human-immunodeficiency-virus-hiv-in-an-132063</loc></url>
<url><loc>https://curecurrent.com/trials/effect-of-multiple-dosing-with-bi-201335-on-the-pharmacokinetics-of-darunavir-co-administered-with-ritonavir-in-healthy-132064</loc></url>
<url><loc>https://curecurrent.com/trials/drug-drug-interaction-of-bi-201335-and-tenofovir-132065</loc></url>
<url><loc>https://curecurrent.com/trials/progesterone-supplementation-for-hiv-positive-pregnant-women-on-anti-retrovirals-132066</loc></url>
<url><loc>https://curecurrent.com/trials/study-to-understand-the-natural-history-of-hiv-aids-in-the-era-of-effective-therapy-sun-study-132067</loc></url>
<url><loc>https://curecurrent.com/trials/medical-marijuana-use-in-hiv-patients-probability-survey-132068</loc></url>
<url><loc>https://curecurrent.com/trials/recovery-management-checkups-for-women-offenders-132069</loc></url>
<url><loc>https://curecurrent.com/trials/behavioral-science-aspects-of-rapid-test-acceptance-132070</loc></url>
<url><loc>https://curecurrent.com/trials/intralesional-bevacizumab-for-treating-aids-associated-kaposi-s-sarcoma-of-the-larynx-pharynx-and-oral-cavity-132071</loc></url>
<url><loc>https://curecurrent.com/trials/resistance-in-hiv-in-north-and-south-132072</loc></url>
<url><loc>https://curecurrent.com/trials/integration-of-buprenorphine-into-hiv-clinical-settings-primary-care-model-pcm-132073</loc></url>
<url><loc>https://curecurrent.com/trials/effectiveness-of-structured-ecosystems-therapy-for-reducing-hiv-risk-behaviors-and-improving-treatment-adherence-in-hiv-132074</loc></url>
<url><loc>https://curecurrent.com/trials/gamma-secretase-inhibitor-pf-03084014-in-treating-patients-with-aids-associated-kaposi-sarcoma-132075</loc></url>
<url><loc>https://curecurrent.com/trials/accuracy-of-the-pima-cd4-test-for-enumeration-of-cd4-t-cell-counts-132076</loc></url>
<url><loc>https://curecurrent.com/trials/isentress-re-examination-study-mk-0518-115-132077</loc></url>
<url><loc>https://curecurrent.com/trials/stocrin-re-examination-study-0831-028-132078</loc></url>
<url><loc>https://curecurrent.com/trials/safety-and-efficacy-of-tenofovir-df-in-hiv-1-infected-adolescents-failing-their-current-antiretroviral-therapy-132079</loc></url>
<url><loc>https://curecurrent.com/trials/relative-bioavailability-study-of-phase-iii-tablet-formulation-of-cabotegravir-132080</loc></url>
<url><loc>https://curecurrent.com/trials/boceprevir-drug-combination-for-hepatitis-c-treatment-in-people-with-and-without-hiv-132081</loc></url>
<url><loc>https://curecurrent.com/trials/exploring-hiv-entry-blockade-as-a-pre-exposure-prophylaxis-strategy-in-women-132082</loc></url>
<url><loc>https://curecurrent.com/trials/demand-creation-for-couples-hiv-counseling-and-testing-132083</loc></url>
<url><loc>https://curecurrent.com/trials/study-to-evaluate-the-pharmacokinetics-of-an-oral-contraceptive-containing-levonorgestrel-and-ethinyl-estradiol-when-co-132084</loc></url>
<url><loc>https://curecurrent.com/trials/tmc114-c214-trial-of-tmc114-administered-with-low-dose-ritonavir-rtv-in-hiv-1-infected-treatment-experienced-patients-132085</loc></url>
<url><loc>https://curecurrent.com/trials/clinical-trial-of-safety-and-pharmacokinetics-of-vm-1500-after-multiple-oral-administration-in-healthy-volunteers-132086</loc></url>
<url><loc>https://curecurrent.com/trials/measuring-the-impact-of-integrating-maternal-and-newborn-hiv-testing-with-childhood-immunization-services-132087</loc></url>
<url><loc>https://curecurrent.com/trials/study-of-immunity-at-the-genital-mucosa-of-hiv-1-infected-and-healthy-women-132088</loc></url>
<url><loc>https://curecurrent.com/trials/study-of-safety-and-pharmacokinetics-in-healthy-volunteers-and-safety-tolerability-and-antiviral-activity-of-vm-1500-in-132089</loc></url>
<url><loc>https://curecurrent.com/trials/a-phase-ii-trial-to-assess-the-safety-and-immunogenicity-of-dna-priming-administered-by-the-id-zetajet-with-or-without-i-132090</loc></url>
<url><loc>https://curecurrent.com/trials/pi-or-nnrti-as-first-line-treatment-of-hiv-in-west-africa-the-piona-trial-132091</loc></url>
<url><loc>https://curecurrent.com/trials/evaluation-of-the-quality-of-self-collected-blood-spot-specimens-for-laboratory-hiv-testing-an-involvement-sub-study-132092</loc></url>
<url><loc>https://curecurrent.com/trials/project-n-liten-hiv-prevention-for-african-american-women-132093</loc></url>
<url><loc>https://curecurrent.com/trials/clinical-study-of-an-aluvia-based-haart-regimen-for-prevention-of-mother-to-child-hiv-transmission-in-africa-132094</loc></url>
<url><loc>https://curecurrent.com/trials/pilot-assessment-of-lopinavir-ritonavir-and-maraviroc-132095</loc></url>
<url><loc>https://curecurrent.com/trials/internet-based-sexual-health-education-for-middle-school-native-american-youth-132096</loc></url>
<url><loc>https://curecurrent.com/trials/the-navigator-project-132097</loc></url>
<url><loc>https://curecurrent.com/trials/longitudinal-study-of-ocular-complications-of-aids-lsoca-132098</loc></url>
<url><loc>https://curecurrent.com/trials/switch-from-tenofovir-to-raltegravir-for-low-bone-mineral-density-132099</loc></url>
<url><loc>https://curecurrent.com/trials/evaluation-of-behavioral-intervention-for-hiv-positive-prisoners-in-nc-and-tx-132100</loc></url>
<url><loc>https://curecurrent.com/trials/brief-intervention-for-drug-misuse-in-the-emergency-department-132101</loc></url>
<url><loc>https://curecurrent.com/trials/raltegravir-added-to-stable-haart-in-hiv-1-infected-subjects-with-viral-suppression-and-low-cd4-recovery-132102</loc></url>
<url><loc>https://curecurrent.com/trials/antiretroviral-adherence-and-quality-of-life-support-for-hiv-patients-in-india-with-twice-daily-interactive-voice-respon-132103</loc></url>
<url><loc>https://curecurrent.com/trials/hormone-replacement-therapy-and-anti-hiv-drugs-in-hiv-infected-postmenopausal-women-132104</loc></url>
<url><loc>https://curecurrent.com/trials/a-study-to-see-if-certain-antioxidants-and-vitamins-will-keep-lactate-levels-down-in-patients-taking-anti-hiv-drugs-132105</loc></url>
<url><loc>https://curecurrent.com/trials/stribild-in-non-nucleoside-resistant-patients-sinnr-study-132106</loc></url>
<url><loc>https://curecurrent.com/trials/a-trial-of-the-urine-lam-strip-test-for-tb-diagnosis-amongst-hospitalized-hiv-infected-patients-132107</loc></url>
<url><loc>https://curecurrent.com/trials/early-antiretroviral-treatment-and-or-early-isoniazid-prophylaxis-against-tuberculosis-in-hiv-infected-adults-anrs-12136-132108</loc></url>
<url><loc>https://curecurrent.com/trials/safety-study-of-raltegravir-in-hiv-hcv-co-infected-patients-132109</loc></url>
<url><loc>https://curecurrent.com/trials/familias-unidas-preventing-substance-abuse-in-hispanic-youth-132110</loc></url>
<url><loc>https://curecurrent.com/trials/behavioral-clinical-and-basic-science-studies-of-non-occupational-post-exposure-prophylaxis-pep-2-132111</loc></url>
<url><loc>https://curecurrent.com/trials/the-role-of-inflammation-and-aging-in-hiv-associated-cardiovascular-risk-132112</loc></url>
<url><loc>https://curecurrent.com/trials/observational-study-of-nevirapine-extended-release-in-human-immunodeficiency-virus-hiv-patients-in-daily-clinical-practi-132113</loc></url>
<url><loc>https://curecurrent.com/trials/strategies-to-increase-hiv-testing-linkages-to-care-and-male-circumcision-in-africa-132114</loc></url>
<url><loc>https://curecurrent.com/trials/addressing-psychosocial-needs-and-hiv-risk-in-indian-msm-132115</loc></url>
<url><loc>https://curecurrent.com/trials/hiv-educational-programs-for-villagers-of-funan-county-or-yingzhou-district-anhui-province-china-132116</loc></url>
<url><loc>https://curecurrent.com/trials/male-partner-involvement-in-the-prevention-of-mtct-of-hiv-132117</loc></url>
<url><loc>https://curecurrent.com/trials/perceptions-of-burden-in-patients-with-late-stage-cancer-and-their-caregivers-132118</loc></url>
<url><loc>https://curecurrent.com/trials/effect-of-bednets-and-a-water-purification-device-on-hiv-disease-progression-among-art-na-ve-patients-in-kenya-132119</loc></url>
<url><loc>https://curecurrent.com/trials/microbicide-safety-and-acceptability-in-young-men-132120</loc></url>
<url><loc>https://curecurrent.com/trials/ucla-amity-parolee-health-promotion-study-132121</loc></url>
<url><loc>https://curecurrent.com/trials/a-72-week-randomized-clinical-trial-comparing-the-safety-and-efficacy-of-three-initial-antiretroviral-regimens-gpo-vir-s-132122</loc></url>
<url><loc>https://curecurrent.com/trials/a-study-of-safety-tolerability-and-immunogenicity-of-a-1-dose-regimen-of-mrkad5-hiv-1-gag-vaccine-versus-the-alvac-hiv-v-132123</loc></url>
<url><loc>https://curecurrent.com/trials/a-study-to-explore-the-association-between-blood-pressure-hiv-and-antiretroviral-therapy-132124</loc></url>
<url><loc>https://curecurrent.com/trials/evaluating-the-effect-of-a-novel-web-based-intervention-to-increase-hiv-testing-in-men-who-have-sex-with-men-132125</loc></url>
<url><loc>https://curecurrent.com/trials/factors-affecting-the-intention-to-take-npep-among-thai-msm-132126</loc></url>
<url><loc>https://curecurrent.com/trials/serosorting-intervention-for-hiv-negative-msm-132127</loc></url>
<url><loc>https://curecurrent.com/trials/cohort-study-of-hiv-1-incidence-among-clients-of-the-thai-red-cross-aids-research-center-bangkok-thailand-132128</loc></url>
<url><loc>https://curecurrent.com/trials/safer-sex-intervention-for-male-clients-of-female-sex-workers-in-tijuana-mexico-132129</loc></url>
<url><loc>https://curecurrent.com/trials/implementation-of-an-efficacious-intervention-for-high-risk-women-in-mexico-132130</loc></url>
<url><loc>https://curecurrent.com/trials/culturally-sensitive-intervention-to-improve-retention-in-hiv-care-for-latino-msm-132131</loc></url>
<url><loc>https://curecurrent.com/trials/effects-of-hiv-and-hepatitis-c-virus-on-the-brain-132132</loc></url>
<url><loc>https://curecurrent.com/trials/determining-the-effect-of-abacavir-on-platelet-activation-132133</loc></url>
<url><loc>https://curecurrent.com/trials/in-vivo-drug-interaction-pharmacokinetic-study-of-tenofovir-1-gel-and-three-commonly-used-vaginal-products-132134</loc></url>
<url><loc>https://curecurrent.com/trials/hiv-testing-strategies-in-the-perinatal-setting-132135</loc></url>
<url><loc>https://curecurrent.com/trials/couples-hiv-counseling-and-testing-for-male-couples-in-the-united-states-132136</loc></url>
<url><loc>https://curecurrent.com/trials/atorvastatin-for-haart-suboptimal-responders-132137</loc></url>
<url><loc>https://curecurrent.com/trials/family-centered-advanced-care-planning-for-adolescents-with-hiv-aids-and-their-families-132138</loc></url>
<url><loc>https://curecurrent.com/trials/adjunct-immunotherapy-with-immunoxel-in-patients-with-tb-and-tb-hiv-132139</loc></url>
<url><loc>https://curecurrent.com/trials/an-evaluation-of-the-pharmacological-interaction-of-lopinavir-r-and-rifampin-132140</loc></url>
<url><loc>https://curecurrent.com/trials/antiviral-therapy-and-hiv-in-the-female-genital-tract-132141</loc></url>
<url><loc>https://curecurrent.com/trials/intervention-development-for-social-stress-mental-health-and-hiv-risk-msm-132142</loc></url>
<url><loc>https://curecurrent.com/trials/effects-of-ribavirin-on-zidovudine-or-stavudine-132143</loc></url>
<url><loc>https://curecurrent.com/trials/salvage-treatment-resistance-testing-and-withdrawal-of-anti-hiv-drugs-for-hiv-patients-failing-current-anti-hiv-treatmen-132144</loc></url>
<url><loc>https://curecurrent.com/trials/raltegravir-activity-in-lymphoid-tissues-132145</loc></url>
<url><loc>https://curecurrent.com/trials/four-drug-combination-therapy-with-zidovudine-lamivudine-1592u89-abacavir-and-141w94-amprenavir-in-hiv-infected-patients-132146</loc></url>
<url><loc>https://curecurrent.com/trials/effectiveness-of-interleukin-2-il-2-plus-anti-hiv-therapy-in-hiv-positive-patients-132147</loc></url>
<url><loc>https://curecurrent.com/trials/pilot-study-acceptability-feasibility-and-efficacy-of-vaginal-insemination-in-hiv-discordant-couples-female-positive-mal-132148</loc></url>
<url><loc>https://curecurrent.com/trials/hiv-screening-take-up-evaluating-incentives-and-opt-out-strategies-132149</loc></url>
<url><loc>https://curecurrent.com/trials/examination-of-b-cell-responses-in-human-blood-132150</loc></url>
<url><loc>https://curecurrent.com/trials/investigation-of-the-effect-of-cenicriviroc-cvc-plus-ftc-tdf-on-cardiovascular-disease-risk-factors-132151</loc></url>
<url><loc>https://curecurrent.com/trials/pilot-study-of-immediate-hiv-treatment-in-guangxi-china-132152</loc></url>
<url><loc>https://curecurrent.com/trials/reducing-cardiovascular-disease-cvd-risk-in-hiv-on-antiretroviral-therapy-over-12-months-132153</loc></url>
<url><loc>https://curecurrent.com/trials/simplification-to-atazanavir-ritonavir-lamivudine-as-maintenance-therapy-132154</loc></url>
<url><loc>https://curecurrent.com/trials/epidemic-history-and-iatrogenic-transmission-of-blood-borne-viruses-in-mid-20th-century-kinshasa-132155</loc></url>
<url><loc>https://curecurrent.com/trials/pilot-study-of-raltegravir-switch-to-resolve-tenofovir-induced-proteinuria-132156</loc></url>
<url><loc>https://curecurrent.com/trials/project-teach-kenya-132157</loc></url>
<url><loc>https://curecurrent.com/trials/project-aware-using-the-emergency-department-ed-to-prevent-sexually-transmitted-infections-stis-in-youth-132158</loc></url>
<url><loc>https://curecurrent.com/trials/incidence-of-oral-candidiasis-prevalence-of-c-dubliniensis-in-hiv-patients-and-in-vitro-azole-susceptibility-132159</loc></url>
<url><loc>https://curecurrent.com/trials/client-centered-counseling-during-routine-opt-out-hiv-testing-in-uganda-132160</loc></url>
<url><loc>https://curecurrent.com/trials/the-feasibility-of-using-a-general-health-screen-to-increase-hiv-testing-in-community-pharmacies-132161</loc></url>
<url><loc>https://curecurrent.com/trials/pharmacokinetic-interactions-between-an-herbal-medicine-african-potato-and-antiretroviral-agents-lopinavir-ritonavir-132162</loc></url>
<url><loc>https://curecurrent.com/trials/genetically-modified-peripheral-blood-stem-cell-transplant-in-treating-patients-with-hiv-associated-non-hodgkin-or-hodgk-132163</loc></url>
<url><loc>https://curecurrent.com/trials/trial-of-tdf-ftc-raltegravir-versus-tdf-ftc-efavirenz-in-hiv-1-infected-women-132164</loc></url>
<url><loc>https://curecurrent.com/trials/safety-and-immunogenicity-study-of-aids-vaccine-combined-use-of-dna-vaccine-and-recombinant-vaccinia-virus-tiantan-132165</loc></url>
<url><loc>https://curecurrent.com/trials/impact-of-rutf-on-body-composition-anemia-and-zinc-status-of-plwha-132166</loc></url>
<url><loc>https://curecurrent.com/trials/aging-hiv-aids-neurocognitive-sequelae-and-functional-consequences-132167</loc></url>
<url><loc>https://curecurrent.com/trials/safety-and-acceptability-of-tenofovir-1-gel-in-adolescent-females-132168</loc></url>
<url><loc>https://curecurrent.com/trials/a-phase-3-open-label-study-to-investigate-the-efficacy-and-safety-of-sofosbuvir-plus-ribavirin-in-chronic-genotype-1-2-3-132169</loc></url>
<url><loc>https://curecurrent.com/trials/liposomal-daunorubicin-in-treating-patients-with-hiv-related-kaposi-s-sarcoma-132170</loc></url>
<url><loc>https://curecurrent.com/trials/risk-of-cv-events-with-efv-vs-efv-free-regimens-132171</loc></url>
<url><loc>https://curecurrent.com/trials/clinical-performance-of-reveal-g4-rapid-hiv-1-antibody-test-132172</loc></url>
<url><loc>https://curecurrent.com/trials/tmc125-tidp35-c213-safety-and-antiviral-activity-of-etravirine-tmc125-in-treatment-experienced-hiv-infected-children-and-132173</loc></url>
<url><loc>https://curecurrent.com/trials/antidepressant-treatment-of-aids-related-depression-132174</loc></url>
<url><loc>https://curecurrent.com/trials/csp-512-options-in-management-with-anti-retrovirals-132175</loc></url>
<url><loc>https://curecurrent.com/trials/hiv-prevention-within-high-risk-bulgarian-and-hungarian-social-networks-132176</loc></url>
<url><loc>https://curecurrent.com/trials/feasibility-of-non-pharmacological-insomnia-therapy-in-people-living-with-hiv-132177</loc></url>
<url><loc>https://curecurrent.com/trials/the-pediatric-hiv-nutrition-study-in-uganda-132178</loc></url>
<url><loc>https://curecurrent.com/trials/safety-and-effectiveness-of-tenofovir-gel-in-the-prevention-of-human-immunodeficiency-virus-hiv-1-infection-in-women-and-132179</loc></url>
<url><loc>https://curecurrent.com/trials/a-study-to-evaluate-the-pharmacokinetic-profile-how-the-body-absorbs-distributes-metabolizes-and-eliminates-a-drug-of-tm-132180</loc></url>
<url><loc>https://curecurrent.com/trials/adapting-and-evaluating-an-ebi-to-prevent-hiv-aids-risk-among-apache-youth-132181</loc></url>
<url><loc>https://curecurrent.com/trials/effectiveness-of-clinician-client-centered-counseling-on-sexual-behaviors-of-antiretroviral-therapy-patients-in-nigeria-132182</loc></url>
<url><loc>https://curecurrent.com/trials/directly-administered-antiretroviral-therapy-daart-among-hiv-1infected-injecting-drug-users-idus-in-chennai-india-132183</loc></url>
<url><loc>https://curecurrent.com/trials/directly-administered-hiv-therapy-in-methadone-clinics-132184</loc></url>
<url><loc>https://curecurrent.com/trials/rapid-evaluation-of-pandemic-h1n1-influenza-vaccine-in-adults-with-hiv-132185</loc></url>
<url><loc>https://curecurrent.com/trials/comparison-of-hiv-clinic-based-treatment-with-buprenorphine-versus-referred-care-in-heroin-dependent-participants-132186</loc></url>
<url><loc>https://curecurrent.com/trials/randomized-controlled-trial-using-patient-reported-outcomes-and-care-managers-to-improve-hiv-medication-adherence-in-rou-132187</loc></url>
<url><loc>https://curecurrent.com/trials/immune-responses-in-patients-treated-with-raltegravir-132188</loc></url>
<url><loc>https://curecurrent.com/trials/evaluation-of-the-pharmacokinetics-of-antituberculosis-drugs-and-tuberculosis-treatment-outcomes-132189</loc></url>
<url><loc>https://curecurrent.com/trials/influence-of-reproductive-cycle-and-menopause-on-hiv-1-infection-and-tfv-gel-activity-132190</loc></url>
<url><loc>https://curecurrent.com/trials/paper-applicator-acceptability-study-132191</loc></url>
<url><loc>https://curecurrent.com/trials/contraception-and-menstrual-cycle-effect-on-pharmacokinetics-pharmacodynamics-and-safety-in-tenofovir-vaginal-gel-use-132192</loc></url>
<url><loc>https://curecurrent.com/trials/study-of-investigational-regimen-combining-fda-approved-hiv-drugs-in-hiv-subjects-experiencing-early-virologic-failure-132193</loc></url>
<url><loc>https://curecurrent.com/trials/intervention-to-assist-msm-disclose-hiv-status-to-casual-sex-partners-132194</loc></url>
<url><loc>https://curecurrent.com/trials/improving-hiv-screening-with-nurse-based-rapid-testing-streamlined-counseling-132195</loc></url>
<url><loc>https://curecurrent.com/trials/health-values-and-spirituality-in-veterans-with-hiv-aids-132196</loc></url>
<url><loc>https://curecurrent.com/trials/a-medication-adherence-intervention-for-hiv-infected-veterans-132197</loc></url>
<url><loc>https://curecurrent.com/trials/measuring-hiv-quality-of-care-132198</loc></url>
<url><loc>https://curecurrent.com/trials/body-image-and-self-care-in-hiv-infected-msm-132199</loc></url>
<url><loc>https://curecurrent.com/trials/examining-hair-to-determine-tenofovir-exposure-132200</loc></url>
<url><loc>https://curecurrent.com/trials/kaiser-permanente-hiv-cohort-study-132201</loc></url>
<url><loc>https://curecurrent.com/trials/safety-pharmacokinetics-pharmacodynamics-and-disintegration-time-of-vaginal-tablets-containing-tenofovir-and-or-emtricit-132202</loc></url>
<url><loc>https://curecurrent.com/trials/effectiveness-of-a-cell-phone-based-program-for-abstinence-and-hiv-risk-prevention-132203</loc></url>
<url><loc>https://curecurrent.com/trials/project-hope-hospital-visit-is-an-opportunity-for-prevention-and-engagement-with-hiv-positive-crack-users-132204</loc></url>
<url><loc>https://curecurrent.com/trials/a-study-to-evaluate-the-safety-of-the-hiv-1-vaccine-mva-b-in-chronic-hiv-1-infected-patients-successfully-treated-with-h-132205</loc></url>
<url><loc>https://curecurrent.com/trials/a-pilot-study-for-toxicity-evaluation-of-hiv-rectal-microbicides-132206</loc></url>
<url><loc>https://curecurrent.com/trials/study-comparing-two-alternatives-of-antiretroviral-therapy-as-post-exposure-prophylaxis-to-hiv-1-tenofovir-emtricitabine-132207</loc></url>
<url><loc>https://curecurrent.com/trials/hpv-in-adolescents-132208</loc></url>
<url><loc>https://curecurrent.com/trials/tenofovir-in-hiv-hbv-coinfection-132209</loc></url>
<url><loc>https://curecurrent.com/trials/enhancing-communication-and-hiv-outcomes-132210</loc></url>
<url><loc>https://curecurrent.com/trials/effects-of-endocrine-health-on-mental-performance-of-men-and-women-using-drugs-132211</loc></url>
<url><loc>https://curecurrent.com/trials/study-comparing-two-alternatives-of-antiretroviral-therapy-as-post-exposure-prophylaxis-to-hiv-1-fovir-emtricitabina-lop-132212</loc></url>
<url><loc>https://curecurrent.com/trials/open-label-pilot-study-of-darunavir-boosted-by-cobicistat-in-combination-with-rilpivirine-to-treat-hiv-na-ve-subjects-132213</loc></url>
<url><loc>https://curecurrent.com/trials/pk-tdf-in-thai-hiv-infected-children-132214</loc></url>
<url><loc>https://curecurrent.com/trials/comparing-the-effectiveness-between-ritonavir-boosted-atazanavir-and-efavirenz-for-the-first-hiv-treatment-132215</loc></url>
<url><loc>https://curecurrent.com/trials/pharmacokinetic-and-efficacy-of-sqv-r-1500-100-plus-tenofovir-emtricitabine-300-200-mg-132216</loc></url>
<url><loc>https://curecurrent.com/trials/comparison-of-epzicom-and-truvada-for-the-initial-once-daily-hiv-treatment-132217</loc></url>
<url><loc>https://curecurrent.com/trials/comparing-continuing-tenofovir-emtricitabine-or-lamivudine-plus-lopinavir-and-switching-to-raltegravir-plus-darunavir-132218</loc></url>
<url><loc>https://curecurrent.com/trials/a-pk-and-salvage-study-for-children-with-hiv-infection-132219</loc></url>
<url><loc>https://curecurrent.com/trials/helping-hiv-infected-patients-in-south-africa-adhere-to-drug-regimens-132220</loc></url>
<url><loc>https://curecurrent.com/trials/simultaneous-versus-sequential-antiretroviral-therapy-arv-therapy-and-mycobacterium-tuberculosis-mtb-treatment-132221</loc></url>
<url><loc>https://curecurrent.com/trials/rapid-hiv-testing-and-counseling-in-high-risk-women-in-shelters-132222</loc></url>
<url><loc>https://curecurrent.com/trials/bioequivalence-study-of-generic-gpo-saquinavir-and-norvir-versus-invirase-and-norvir-132223</loc></url>
<url><loc>https://curecurrent.com/trials/lopinavir-ritonavir-lpv-r-tablet-in-hiv-infected-children-132224</loc></url>
<url><loc>https://curecurrent.com/trials/lopinavir-ritonavir-monotherapy-in-children-132225</loc></url>
<url><loc>https://curecurrent.com/trials/phase-ii-randomized-study-of-physiologic-testosterone-replacement-in-premenopausal-hiv-positive-women-132226</loc></url>
<url><loc>https://curecurrent.com/trials/evaluating-the-safety-and-priming-response-of-an-hiv-vaccine-regimen-in-healthy-hiv-uninfected-adults-132227</loc></url>
<url><loc>https://curecurrent.com/trials/pediatric-study-for-appropriate-dose-of-ritonavir-boosted-lopinavir-in-thai-hiv-infected-children-pearl-132228</loc></url>
<url><loc>https://curecurrent.com/trials/conventional-vaccine-and-intradermal-vaccine-among-hiv-infected-young-subjects-132229</loc></url>
<url><loc>https://curecurrent.com/trials/impaact-p1074-long-term-outcomes-in-hiv-infected-infants-children-and-adolescents-132230</loc></url>
<url><loc>https://curecurrent.com/trials/enhanced-prevention-in-couples-feasibility-study-2-132231</loc></url>
<url><loc>https://curecurrent.com/trials/enhanced-hiv-prevention-in-couples-feasibility-study-1-132232</loc></url>
<url><loc>https://curecurrent.com/trials/study-to-evaluate-changes-in-cd4-on-replacing-tdf-with-abc-or-ddi-tdf-with-abc-3tc-132233</loc></url>
<url><loc>https://curecurrent.com/trials/the-first-failure-study-132234</loc></url>
<url><loc>https://curecurrent.com/trials/hiv-medication-adherence-in-underserved-populations-132235</loc></url>
<url><loc>https://curecurrent.com/trials/the-mochudi-prevention-project-art-protocol-132236</loc></url>
<url><loc>https://curecurrent.com/trials/a-study-of-dementia-and-neurological-problems-in-hiv-infected-patients-who-are-participating-in-actg-a5175-132237</loc></url>
<url><loc>https://curecurrent.com/trials/assessing-hiv-related-oral-mucosal-disease-and-using-saliva-to-measure-viral-load-132238</loc></url>
<url><loc>https://curecurrent.com/trials/observational-study-of-specificity-of-mycobacterium-tuberculosis-screening-and-diagnostics-in-hiv-infected-individuals-132239</loc></url>
<url><loc>https://curecurrent.com/trials/evaluating-a-microfinance-intervention-for-high-risk-women-in-mongolia-132240</loc></url>
<url><loc>https://curecurrent.com/trials/improving-effective-contraceptive-use-among-opioid-maintained-women-132241</loc></url>
<url><loc>https://curecurrent.com/trials/a-study-to-treat-subjects-with-telaprevir-ribavirin-and-peginterferon-who-are-coinfected-with-hiv-and-hepatitis-c-virus-132242</loc></url>
<url><loc>https://curecurrent.com/trials/phase-1-dose-escalation-study-of-autologous-t-cells-genetically-modified-at-the-ccr5-gene-by-zinc-finger-nucleases-in-hi-132243</loc></url>
<url><loc>https://curecurrent.com/trials/atazanavir-and-lamivudine-for-treatment-simplification-132244</loc></url>
<url><loc>https://curecurrent.com/trials/pilot-opened-trial-in-hiv-infected-patients-including-an-investigational-marketed-product-132245</loc></url>
<url><loc>https://curecurrent.com/trials/safety-and-efficacy-study-of-cp-675-206-in-hiv-infected-patients-132246</loc></url>
<url><loc>https://curecurrent.com/trials/efficacy-and-safety-of-temazepam-in-hiv-seropositive-patients-with-insomnia-132247</loc></url>
<url><loc>https://curecurrent.com/trials/effect-of-a-change-in-hiv-therapy-on-liver-steatosis-inflammation-and-fibrosis-132248</loc></url>
<url><loc>https://curecurrent.com/trials/increasing-haart-induced-immune-restoration-with-cyclosporine-132249</loc></url>
<url><loc>https://curecurrent.com/trials/score-system-for-prediction-risk-and-early-diagnosis-of-hcc-in-hiv-hcv-patients-132250</loc></url>
<url><loc>https://curecurrent.com/trials/standard-antiretroviral-v-multi-class-therapy-in-acutely-hiv-1-infected-antiretroviral-na-ve-subjects-adarc-2007-01-132251</loc></url>
<url><loc>https://curecurrent.com/trials/metformin-for-hiv-inflammation-132252</loc></url>
<url><loc>https://curecurrent.com/trials/rapid-hiv-testing-for-emergency-department-patients-132253</loc></url>
<url><loc>https://curecurrent.com/trials/a-comparison-of-nelfinavir-plus-saquinavir-plus-delavirdine-or-3tc-zdv-versus-nelfinavir-plus-3tc-zdv-in-hiv-infected-pa-132254</loc></url>
<url><loc>https://curecurrent.com/trials/use-of-endopat-for-measurements-of-endothelial-dysfunction-in-hiv-infected-children-and-healthy-controls-132255</loc></url>
<url><loc>https://curecurrent.com/trials/a-study-of-the-safety-and-effectiveness-of-an-hiv-vaccine-for-hiv-positive-patients-receiving-anti-hiv-drugs-for-at-leas-132256</loc></url>
<url><loc>https://curecurrent.com/trials/optimal-treatment-for-kidney-disease-in-hiv-infected-adults-132257</loc></url>
<url><loc>https://curecurrent.com/trials/a-study-of-patients-who-recently-have-been-infected-with-hiv-132258</loc></url>
<url><loc>https://curecurrent.com/trials/evaluation-of-specific-infection-fighting-cells-for-prediction-of-immune-response-to-anti-hiv-and-immune-boosting-medica-132259</loc></url>
<url><loc>https://curecurrent.com/trials/effectiveness-of-adding-interleukin-2-to-anti-hiv-drugs-in-patients-recently-infected-with-hiv-132260</loc></url>
<url><loc>https://curecurrent.com/trials/intervention-for-those-recently-informed-of-seropositive-status-iriss-132261</loc></url>
<url><loc>https://curecurrent.com/trials/a-randomized-trial-of-iud-versus-hormonal-contraception-in-hiv-infected-women-in-zambia-132262</loc></url>
<url><loc>https://curecurrent.com/trials/evaluation-of-healing-at-three-time-intervals-and-potential-for-spontaneous-detachment-132263</loc></url>
<url><loc>https://curecurrent.com/trials/thistle-the-hiv-hcv-silibinin-trial-132264</loc></url>
<url><loc>https://curecurrent.com/trials/evaluation-of-residual-platelet-reactivity-after-acute-coronary-syndrome-st-st-in-hiv-132265</loc></url>
<url><loc>https://curecurrent.com/trials/first-study-to-evaluate-the-capacity-of-maraviroc-drug-to-protect-against-hiv-infection-in-samples-of-rectal-mucosa-from-132266</loc></url>
<url><loc>https://curecurrent.com/trials/effectiveness-of-the-diaphragm-for-hiv-prevention-132267</loc></url>
<url><loc>https://curecurrent.com/trials/genetic-predictors-of-raltegravir-penetration-into-cerebrospinal-fluid-132268</loc></url>
<url><loc>https://curecurrent.com/trials/a-phase-i-trial-of-intranasal-peptide-t-safety-toxicity-and-pharmacokinetics-in-human-immunodeficiency-virus-1-hiv-1-inf-132269</loc></url>
<url><loc>https://curecurrent.com/trials/a-phase-i-trial-of-peptide-t-efficacy-for-the-neuropsychiatric-complications-of-acquired-immunodeficiency-syndrome-aids-132270</loc></url>
<url><loc>https://curecurrent.com/trials/trial-to-improve-access-to-pmtct-services-and-reduce-hiv-transmission-from-mother-to-child-132271</loc></url>
<url><loc>https://curecurrent.com/trials/breather-penta-16-short-cycle-therapy-sct-5-days-on-2-days-off-in-young-people-with-chronic-hiv-infection-132272</loc></url>
<url><loc>https://curecurrent.com/trials/a-worldwide-phase-i-dose-escalating-study-of-a-3-dose-regimen-of-the-mrkad5-clade-b-vaccine-in-healthy-adults-v520-018-132273</loc></url>
<url><loc>https://curecurrent.com/trials/interaction-study-to-assess-the-pharmacokinetic-interaction-of-oral-administration-of-rifapentine-on-atripla-in-hiv-pati-132274</loc></url>
<url><loc>https://curecurrent.com/trials/oral-auranofin-for-reduction-of-latent-viral-reservoir-in-patients-with-hiv-infection-132275</loc></url>
<url><loc>https://curecurrent.com/trials/a-study-of-the-pharmacokinetics-and-antiviral-activity-of-dolutegravir-in-the-central-nervous-system-in-hiv-1-infected-a-132276</loc></url>
<url><loc>https://curecurrent.com/trials/study-to-evaluate-the-safety-and-efficacy-of-a-single-tablet-regimen-of-emtricitabine-rilpivirine-tenofovir-disoproxil-f-132277</loc></url>
<url><loc>https://curecurrent.com/trials/promise-ebf-safety-and-efficacy-of-exclusive-breastfeeding-promotion-in-the-era-of-hiv-in-sub-saharan-africa-132278</loc></url>
<url><loc>https://curecurrent.com/trials/effect-of-vicriviroc-on-hiv-ribonucleic-acid-rna-levels-in-cerebrospinal-fluid-study-p05241-132279</loc></url>
<url><loc>https://curecurrent.com/trials/atazanavir-ritonavir-once-daily-raltegravir-twice-daily-switch-study-in-hiv-1-infected-patients-132280</loc></url>
<url><loc>https://curecurrent.com/trials/post-marketing-surveillance-of-hiv-infected-patients-with-chronic-hepatitis-c-treated-with-pegintron-pen-and-rebetol-stu-132281</loc></url>
<url><loc>https://curecurrent.com/trials/substance-use-disorders-in-hiv-people-of-cameroon-132282</loc></url>
<url><loc>https://curecurrent.com/trials/determining-the-barriers-and-motivations-to-clinical-trial-participation-132283</loc></url>
<url><loc>https://curecurrent.com/trials/antiviral-activity-of-peg-ifn-alpha-2a-in-chronic-hiv-1-infection-132284</loc></url>
<url><loc>https://curecurrent.com/trials/behavioral-counseling-intervention-trial-to-reduce-alcohol-related-sexual-risk-behavior-among-hiv-negative-men-in-namibi-132285</loc></url>
<url><loc>https://curecurrent.com/trials/preparedness-study-hpv-vaccine-132286</loc></url>
<url><loc>https://curecurrent.com/trials/efficacy-and-safety-of-vicriviroc-in-hiv-infected-treatment-na-ve-subjects-study-p04875-132287</loc></url>
<url><loc>https://curecurrent.com/trials/registry-to-assess-long-term-outcome-in-hiv-subjects-who-participated-in-phase-2-and-3-clinical-trials-involving-vicrivi-132288</loc></url>
<url><loc>https://curecurrent.com/trials/intradermal-versus-intramuscular-polio-vaccine-booster-in-hiv-infected-subjects-132289</loc></url>
<url><loc>https://curecurrent.com/trials/family-planning-knowledge-attitudes-and-practices-of-postpartum-malawian-women-132290</loc></url>
<url><loc>https://curecurrent.com/trials/raltegravir-switch-for-toxicity-or-adverse-events-132291</loc></url>
<url><loc>https://curecurrent.com/trials/a-study-of-safety-tolerability-and-immunogenicity-of-the-mrkad5-gag-pol-nef-vaccine-in-healthy-adults-v520-016-132292</loc></url>
<url><loc>https://curecurrent.com/trials/phase-i-iia-dose-escalation-clinical-study-of-vac-3s-132293</loc></url>
<url><loc>https://curecurrent.com/trials/effect-of-rosuvastatin-on-endothelial-function-132294</loc></url>
<url><loc>https://curecurrent.com/trials/innove-study-a-study-of-3-months-induction-with-fuzeon-enfuvirtide-optimized-background-ob-versus-ob-alone-in-hiv-1-infe-132295</loc></url>
<url><loc>https://curecurrent.com/trials/safety-and-immunogenicity-study-of-recombinant-modified-vaccinia-virus-ankara-mva-virus-to-treat-hiv-infection-132296</loc></url>
<url><loc>https://curecurrent.com/trials/open-label-pilot-study-to-evaluate-switching-from-a-regimen-consisting-of-raltegravir-plus-emtricitabine-tenofovir-df-fi-132297</loc></url>
<url><loc>https://curecurrent.com/trials/stepping-stones-program-for-preventing-hiv-infection-in-residents-of-rural-south-african-communities-132298</loc></url>
<url><loc>https://curecurrent.com/trials/a-pilot-study-to-examine-efficacy-of-peer-mentoring-in-promoting-medication-adherence-among-people-living-with-hiv-aids-132299</loc></url>
<url><loc>https://curecurrent.com/trials/improving-uptake-of-early-infant-diagnosis-of-hiv-for-the-prevention-of-mother-to-child-transmission-of-hiv-132300</loc></url>
<url><loc>https://curecurrent.com/trials/non-interventional-observational-study-with-viramune-in-hiv-to-evaluate-gender-specific-data-132301</loc></url>
<url><loc>https://curecurrent.com/trials/use-of-the-shang-ring-circumcision-device-in-boys-below-18-years-old-in-kenya-132302</loc></url>
<url><loc>https://curecurrent.com/trials/representations-and-acceptability-of-hiv-therapeutic-vaccine-in-a-cohort-of-hiv-1-infected-outpatients-followed-at-hospi-132303</loc></url>
<url><loc>https://curecurrent.com/trials/non-interventional-observational-study-with-viramune-plus-antiretroviral-in-hiv-infected-patients-132304</loc></url>
<url><loc>https://curecurrent.com/trials/the-safety-and-effectiveness-of-clarithromycin-in-the-prevention-of-mycobacterium-avium-complex-mac-infection-in-hiv-inf-132305</loc></url>
<url><loc>https://curecurrent.com/trials/text-messaging-to-improve-adherence-to-clinic-visits-and-reduce-early-resumption-of-sexual-intercourse-after-male-circum-132306</loc></url>
<url><loc>https://curecurrent.com/trials/a-study-of-decreased-mental-function-associated-with-hiv-132307</loc></url>
<url><loc>https://curecurrent.com/trials/the-safety-and-effectiveness-of-clarithromycin-plus-ethambutol-used-with-or-without-clofazimine-in-the-treatment-of-mac-132308</loc></url>
<url><loc>https://curecurrent.com/trials/efficacy-and-tolerance-of-peg-interferon-alpha-2a-added-to-tenofovir-and-emtricitabine-in-aghbe-positive-hbv-hiv-co-infe-132309</loc></url>
<url><loc>https://curecurrent.com/trials/prediction-and-pathogenesis-of-the-immune-reconstitution-inflammatory-syndrome-132310</loc></url>
<url><loc>https://curecurrent.com/trials/efficacy-of-pegylated-interferon-plus-ribavirin-plus-nitazoxanide-in-hcv-genotype-4-and-hiv-coinfection-132311</loc></url>
<url><loc>https://curecurrent.com/trials/developing-and-assessing-a-community-based-model-of-antiretroviral-care-132312</loc></url>
<url><loc>https://curecurrent.com/trials/immunogenicity-and-safety-of-different-dosing-schedules-of-trivalent-influenza-vaccine-in-hiv-infected-pregnant-women-132313</loc></url>
<url><loc>https://curecurrent.com/trials/safety-tolerability-and-adherence-to-co-formulated-tenofovir-emtricitabine-rilpivirine-used-as-hiv-nonoccupational-post-132314</loc></url>
<url><loc>https://curecurrent.com/trials/therapeutic-schools-affect-management-and-hiv-prevention-132315</loc></url>
</urlset>
